Stefan Agewall

Om mig
Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Om mig

Stefan Agewall är gästprofessor i kardiovaskulär forskning med fokus på klimatets påverkan vid institutionen för kliniska vetenskaper, Danderyds sjukhus vid Karolinska Institutet från den 1 november 2023. Han är också professor i kardiologi vid Oslo Universitet i Norge.

Forskningsbeskrivning

Stefan Agewall och hans forskargrupp undersöker hur temperaturer och temperaturförändringar påverkar risken för hjärtinfarkt. De undersöker också hur luftföroreningar och läkemedelsbehandling påverkar sjukdomsrisken, i relation till temperaturer och temperaturförändringar. För att göra detta använder de sig av data från SMHI och SWEDEHEART-registret med nästan 229 000 patienter. Snabba temperaturförändringar förväntas öka i världen som en effekt av klimatförändringarna. Om det visar sig att vissa temperaturer eller temperaturförändringar ökar risken för hjärtinfarkt kommer patienterna kunna ges bättre råd kring hur de ska agera i dessa situationer. Om vissa läkemedel visar sig påverka risken så kan läkemedelsbehandlingarna anpassas. På samhällsnivå är det också viktigt att veta om och hur luftföroreningar påverkar hjärtkärlsjukdom.

Artiklar

Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2024;10(7):608-613
Management of dyslipidaemia in patients with comorbidities: facing the challenge
Mayer G; Dobrev D; Kaski JC; Semb AG; Huber K; Zirlik A; Agewall S; Drexel H
Journal article: EUROPEAN HEART JOURNAL. 2024;45:ehae666.3604
Effects of short-term exposures to lower air temperature and cold spells on myocardial infarction hospital admissions: a nationwide study in Sweden
Ni W; Stafoggia M; Zhang S; Ljungman P; Breitner S; Bont JD; Jernberg T; Atar D; Agewall S; Schneider A
Journal article: EUROPEAN HEART JOURNAL. 2024;45:ehae666.3605
Short-term effects of ambient temperature variability on myocardial infarction hospitalizations in Sweden: A nationwide case-crossover study
Ni W; Stafoggia M; Zhang S; Ljungman P; Breitner S; Bont JD; Jernberg T; Atar D; Schneider A; Agewall S
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2024;10(6):479-480
Focus on different lipid-lowering treatment and genetic testing for optimal pharmacotherapy use in the clinic
Agewall S
Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2024;84(13):1149-1159
Short-Term Effects of Lower Air Temperature and Cold Spells on Myocardial Infarction Hospitalizations in Sweden
Ni W; Stafoggia M; Zhang S; Ljungman P; Breitner S; de Bont J; Jernberg T; Atar D; Agewall S; Schneider A
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2024;10(5):370
European Heart Journal-Cardiovascular Pharmacotherapy to become fully open access in 2025
Agewall S
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2024;10(5):367-369
The search for the holy grail: the balance between the risk of thrombosis and bleeding in patients
Agewall S
Article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2024;10(5):444-453
Oral anticoagulation in patients with left ventricular thrombus: a systematic review and meta-analysis
Haller PM; Kazem N; Agewall S; Borghi C; Ceconi C; Dobrev D; Cerbai E; Grove EL; Kaski JC; Lewis BS; Niessner A; Rocca B; Rosano G; Savarese G; Schnabel RB; Semb AG; Sossalla S; Wassmann S; Sulzgruber P
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2024;10(4):265-266
Special focus on the new anti-diabetic drugs
Agewall S
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2024;13(13):e034709
Abbreviated Versus Standard Dual Antiplatelet Therapy Times After Percutaneous Coronary Intervention in Patients With High Bleeding Risk With Acute Coronary Syndrome: Insights From the SWEDEHEART Registry
Hakansson A; Koul S; Omerovic E; Andersson J; James S; Agewall S; Mokhtari A; van der Pals J; Wester A; Szummer K; Jernberg T; Erlinge D; Mohammad MA
Journal article: CLINICAL RESEARCH IN CARDIOLOGY. 2024;113(6):822-830
Glycaemic control and insulin therapy are significant confounders of the obesity paradox in patients with heart failure and diabetes mellitus
Froehlich H; Bossmeyer A; Kazmi S; Goode KM; Agewall S; Atar D; Grundtvig M; Frey N; Cleland JGF; Frankenstein L; Clark AL; Taeger T
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2024;10(1):3-4
Anticoagulation in cancer-associated thrombosis: how long should the therapy be?
Xiong W; Agewall S; Yamashita Y
Journal article: EUROPEAN HEART JOURNAL. 2023;44:ehad655.1371
Abbreviated versus standard dual antiplatelet therapy time after PCI in high bleeding risk patients with acute coronary syndrome - a report from the SWEDEHEART registry
Haakansson A; Koul S; Omerovic E; Andersson J; Agewall S; James S; Mokhtari A; Van der Pals J; Wester A; Szummer K; Jernberg T; Erlinge D; Mohammad MA
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023;24(18):14143
Helicobacter pylori and Pro-Inflammatory Protein Biomarkers in Myocardial Infarction with and without Obstructive Coronary Artery Disease
Warme J; Sundqvist MO; Hjort M; Agewall S; Collste O; Ekenback C; Frick M; Henareh L; Hofman-Bang C; Spaak J; Sorensson P; Y-Hassan S; Svensson P; Lindahl B; Hofmann R; Tornvall P
Article: EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES. 2023;9(6):639-644
Health-related quality-of-life up to one year after myocardial infarction with non-obstructive coronary arteries
Berg E; Agewall S; Brolin EB; Caidahl K; Cederlund K; Collste O; Daniel M; Ekenback C; Jensen J; Y-Hassan S; Henareh L; Maret E; Spaak J; Sorensson P; Tornvall P; Lynga P
Article: EUROPEAN HEART JOURNAL OPEN. 2023;3(5):oead089
Intima-media thickness at the near or far wall of the common carotid artery in cardiovascular risk assessment.
Seekircher L; Tschiderer L; Lind L; Safarova MS; Kavousi M; Ikram MA; Lonn E; Yusuf S; Grobbee DE; Kastelein JJP; Visseren FLJ; Walters M; Dawson J; Higgins P; Agewall S; Catapano A; de Groot E; Espeland MA; Klingenschmid G; Magliano D; Olsen MH; Preiss D; Sander D; Skilton M; Zozulińska-Ziółkiewicz DA; Grooteman MPC; Blankestijn PJ; Kitagawa K; Okazaki S; Manzi MV; Mancusi C; Izzo R; Desvarieux M; Rundek T; Gerstein HC; Bots ML; Sweeting MJ; Lorenz MW; Willeit P
Article: JOURNAL OF REHABILITATION MEDICINE. 2023;55:4569-jrm4569
EVALUATION OF A STRUCTURALIZED SICK-LEAVE PROGRAMME COMPARED WITH USUAL CARE SICK-LEAVE MANAGEMENT FOR PATIENTS AFTER AN ACUTE MYOCARDIAL INFARCTION
Tjessem L; Agewall S
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2023;12(12):e027657
Association of Intima-Media Thickness Measured at the Common Carotid Artery With Incident Carotid Plaque: Individual Participant Data Meta-Analysis of 20 Prospective Studies
Tschiderer L; Seekircher L; Izzo R; Mancusi CV; Manzi M; Baldassarre D; Amato M; Tremoli E; Veglia F; Tuomainen T-P; Kauhanen J; Voutilainen A; Iglseder B; Lind L; Rundek T; Desvarieux M; Kato A; de Groot E; Asci G; Ok E; Agewall S; Beulens JWJD; Byrne CC; Calder PC; Gerstein H; Gresele P; Klingenschmid G; Nagai MH; Olsen M; Parraga GS; Safarova M; Sattar N; Skilton M; Stehouwer CDA; Uthoff HA; van Agtmael MA; van der Heijden AA; Zozulinska-Ziolkiewicz D; Park H-W; Lee M-S; Bae J-H; Beloqui OF; Landecho M; Plichart M; Ducimetiere P; Empana JP; Bokemark L; Bergstroem G; Schmidt C; Castelnuovo S; Calabresi LD; Norata G; Grigore L; Catapano A; Zhao D; Wang M; Liu J; Ikram MA; Kavousi ML; Bots MJ; Sweeting MW; Lorenz M; Willeit P
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2023;9(4):353-370
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022
Tamargo J; Agewall S; Borghi C; Ceconi C; Cerbai E; Dan GA; Ferdinandy P; Grove EL; Rocca B; Sulzgruber P; Semb AG; Sossalla S; Niessner A; Kaski JC; Dobrev D
Journal article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2023;81(11):1130-1132
RESPONSE: Climate Change and Health: Challenges, Opportunities, and the Need for Action.
Schneider A; Atar D; Agewall S
Journal article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2023;81(8):2114
SMALL-AREA ANALYSIS OF SHORT-TERM ASSOCIATIONTWEEN HEAT AND CARDIOVASCULAR MORTALITY IN FOUR EUROPEAN COUNTRIES
Agewall S; Breitner S; Rai M; Stafoggia M; De'Donato F; Samoli E; Zafeiratou S; Fernandez LV; Rao S; Gasparrini A; Masselot P; Aunan K; Schneider A; Zhang S
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2023;9(2):119-120
Focus on lipid treatment
Agewall S
Article: BIOMEDICINE & PHARMACOTHERAPY. 2023;158:114064
Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?
Martinez-Montesinos L; Rivera-Caravaca JM; Agewall S; Soler E; Lip GYH; Marin F; Roldan V
Journal article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2023;81(11):1130-1132
RESPONSE: Climate Change and Health Challenges, Opportunities, and the Need for Action
Schneider A; Atar D; Agewall S
Journal article: PLOS ONE. 2023;18(2):e0281155
High-sensitivity cardiac troponin T is associated with disease activity in patients with inflammatory arthritis
Nguyen THP; Fagerland MW; Hollan I; Whist JE; Feinberg MWW; Agewall S
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;9(1):1-3
Pharmacological treatment of CVD
Agewall S
Journal article: JOURNAL OF CLINICAL MEDICINE. 2022;11(24):7330
Effects of Antirheumatic Treatment on Cell Cholesterol Efflux and Loading Capacity of Serum Lipoproteins in Spondylarthropathies
Hokstad I; Greco D; Deyab G; Fagerland MW; Agewall S; Hjeltnes G; Zimetti F; Bernini F; Ronda N; Hollan I
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(8):754-755
To treat or not to treat
Agewall S
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(8):753
Future of European Heart Journal Cardiovascular Pharmacotherapy
Agewall S
Journal article: EUROPEAN HEART JOURNAL. 2022;43(45):4719-4721
Toward personalized medicine for cardiovascular pharmacotherapy
Tamargo J; Hasegawa K; Agewall S
Journal article: EUROPEAN HEART JOURNAL. 2022;43(37):3512-3527
Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week.
De Caterina R; Agewall S; Andreotti F; Angiolillo DJ; Bhatt DL; Byrne RA; Collet J-P; Eikelboom J; Fanaroff AC; Gibson CM; Goette A; Hindricks G; Lip GYH; Potpara T; Thiele H; Lopes RD; Galli M
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(6):537-538
Prevention is still the key to success
Agewall S
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(5):431-433
Focus on optimizing treatment of coronary heart disease
Agewall S
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(4):323-324
Focus on different aspects of atrial fibrillation
Agewall S
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(3):213-215
New cardiology aspects of triple antithrombotic therapy, diabetes without insulin therapy as a risk factor in atrial fibrillation, treatment of gout, cholesterol lowering treatment, prostate cancer treatment, out-of-hospital cardiac arrest, Fabry disease, beta-blocker use after myocardial infarction in patients with normal ejection fraction, cardio-renal benefits of SGLT2 Inhibitors and interpretation of clinical trials
Agewall S
Article: JOURNAL OF INTERNAL MEDICINE. 2022;291(3):327-337
Antiphospholipid antibodies in patients with myocardial infarction with and without obstructive coronary arteries
Svenungsson E; Spaak J; Strandberg K; Wallen HN; Agewall S; Brolin EB; Collste O; Daniel M; Ekenback C; Frick M; Henareh L; Malmqvist K; Elvin K; Sorensson P; Y-Hassan S; Hofman-Bang C; Tornvall P
Article: JOURNAL OF WOMENS HEALTH. 2022;31(3):310-320
The Association of Smoking with Hospitalization and Mortality Differs According to Sex in Patients with Heart Failure Following Myocardial Infarction
Hall TS; orn S; Zannad F; Rossignol P; Duarte K; Solomon SD; Atar D; Agewall S; Dickstein K; Girerd N
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(2):105-107
Optimizing individual heart failure treatment
Agewall S
Article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(1):100-103
Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Magavern EF; Kaski JC; Turner RM; Drexel H; Janmohamed A; Scourfield A; Burrage D; Floyd CN; Adeyeye E; Tamargo J; Lewis BS; Kjeldsen KP; Niessner A; Wassmann S; Sulzgruber P; Borry P; Agewall S; Semb AG; Savarese G; Pirmohamed M; Caulfield MJ
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(1):1-3
Treatment with dual antiplatelet therapy after an acute coronary event may often be tailor-made for the patient
Agewall S
Article: PLOS ONE. 2022;17(2):e0264628
Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis
Nguyen THP; Hokstad I; Fagerland MW; Mollnes TE; Hollan I; Feinberg MW; Hjeltnes G; Eilertsen GO; Mikkelsen K; Agewall S
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2021;7(6):461-462
Unsolved pharmacological issues with cardiology
Agewall S
Article: CLINICAL CARDIOLOGY. 2021;44(11):1567-1574
Plasma catecholamine levels in the acute and subacute stages of takotsubo syndrome: Results from the Stockholm myocardial infarction with normal coronaries 2 study
Y-Hassan S; Sorensson P; Ekenback C; Lundin M; Agewall S; Brolin EB; Caidahl K; Cederlund K; Collste O; Daniel M; Jensen J; Hofman-Bang C; Lynga P; Maret E; Sarkar N; Spaak J; Winnberg O; Ugander M; Tornvall P; Henareh L
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2021;7(5):361-362
More knowledge about atrial fibrillation, still we need to learn
Agewall S
Article: JACC-CARDIOVASCULAR IMAGING. 2021;14(9):1774-1783
Early Comprehensive Cardiovascular Magnetic Resonance Imaging in Patients With Myocardial Infarction With Nonobstructive Coronary Arteries
Sorensson P; Ekenback C; Lundin M; Agewall S; Brolin EB; Caidahl K; Cederlund K; Collste O; Daniel M; Jensen J; Y-Hassan S; Henareh L; Hofman-Bang C; Lynga P; Maret E; Sarkar N; Spaak J; Winnberg O; Ugander M; Tornvall P
Journal article: EUROPEAN HEART JOURNAL. 2021;42(30):2909-2911
Fluoroquinolone use and valvular heart disease: is the jury still out?
Tamargo J; Agewall S
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2021;7(4):261-262
Adherence to pharmacological treatment: how can we improve?
Agewall S
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2021;7(3):169-170
Different aspects of giving the optimal antiplatelet treatment
Agewall S
Article: AMERICAN HEART JOURNAL. 2021;231:96-104
Randomized evaluation of beta blocker and ACE-inhibitor/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT): Rationale and design
Nordenskjoeld AM; Agewall S; Atar D; Baron T; Beltrame J; Bergstroem O; Erlinge D; Gale CP; Lopez-Pais J; Jernberg T; Johansson P; Ravn-Fisher A; Reynolds HR; Somaratne JB; Tornvall P; Lindahl B
Article: PLOS ONE. 2021;16(7):e0253247
Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis
Deyab G; Reine TM; Tram TV; Jenssen T; Hjeltnes G; Agewall S; Mikkelsen K; Forre O; Fagerland MW; Kolset SO; Hollan I
Article: PLOS ONE. 2021;16(6):e0253793
Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis
Nguyen THP; Fagerland MW; Deyab G; Hjeltnes G; Hollan I; Feinberg MW; Eilertsen GO; Mikkelsen K; Agewall S
Journal article: EUROPEAN HEART JOURNAL. 2020;41:ehaa946.1640-1640
The association of smoking to cardiovascular death differs according to age and sex following myocardial infarction complicated by heart failure or left ventricular dysfunction
Hall TS; Orn S; Zannad F; Rossignol P; Duarte K; Solomon S; Atar D; Agewall S; Dickstein K; Girerd N
Article: CIRCULATION. 2020;142(7):621-642
Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients
Willeit P; Tschiderer L; Allara E; Reuber K; Seekircher L; Gao L; Liao X; Lonn E; Gerstein HC; Yusuf S; Brouwers FP; Asselbergs FW; van Gilst W; Anderssen SA; Grobbee DE; Kastelein JJP; Visseren FLJ; Ntaios G; Hatzitolios AI; Savopoulos C; Nieuwkerk PT; Stroes E; Walters M; Higgins P; Dawson J; Gresele P; Guglielmini G; Migliacci R; Ezhov M; Safarova M; Balakhonova T; Sato E; Amaha M; Nakamura T; Kapellas K; Jamieson LM; Skilton M; Blumenthal JA; Hinderliter A; Sherwood A; Smith PJ; van Agtmael MA; Reiss P; van Vonderen MGA; Kiechl S; Klingenschmid G; Sitzer M; Stehouwer CDA; Uthoff H; Zou Z-Y; Cunha AR; Neves MF; Witham MD; Park H-W; Lee M-S; Bae J-H; Bernal E; Wachtell K; Kjeldsen SE; Olsen MH; Preiss D; Sattar N; Beishuizen E; Huisman MV; Espeland MA; Schmidt C; Agewall S; Ok E; Asci G; de Groot E; Grooteman MPC; Blankestijn PJ; Bots ML; Sweeting MJ; Thompson SG; Lorenz MW
Article: REVISTA ESPANOLA DE CARDIOLOGIA. 2020;73(6):495.e1-495.e61
2019 ESC Guide on the Diagnosis and Treatment of Chronic Coronary Syndromes
Knuuti J; Wijns W; Saraste A; Capodanno D; Barbato E; Funck-Brentano C; Prescott E; Storey RF; Deaton C; Cuisset T; Agewall S; Dickstein K; Edvardsen T; Escaned J; Gersh BJ; Svitil P; Gilard M; Hasdai D; Hatala R; Mahfoud F; Masip J; Muneretto C; Valgimigli M; Achenbach S; Bax JJ
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2020;27(3):234-243
Progression of conventional cardiovascular risk factors and vascular disease risk in individuals: insights from the PROG-IMT consortium
Bahls M; Lorenz MW; Doerr M; Gao L; Kitagawa K; Tuomainen T-P; Agewall S; Berenson G; Catapano AL; Norata GD; Bots ML; van Gilst W; Asselbergs FW; Brouwers FP; Uthoff H; Sander D; Poppert H; Olsen MH; Empana JP; Schminke U; Baldassarre D; Veglia F; Franco OH; Kavousi M; de Groot E; Mathiesen EB; Grigore L; Polak JF; Rundek T; Stehouwer CDA; Skilton MR; Hatzitolios AI; Savopoulos C; Ntaios G; Plichart M; McLachlan S; Lind L; Willeit P; Steinmetz H; Desvarieux M; Ikram MA; Johnsen SH; Schmidt C; Willeit J; Ducimetiere P; Price JF; Bergstrom G; Kauhanen J; Kiechl S; Sitzer M; Bickel H; Sacco RL; Hofman A; Voelzke H; Thompson SG
Article: EUROPEAN HEART JOURNAL. 2020;41(4):543-603
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS).
Konstantinides SV; Meyer G; Becattini C; Bueno H; Geersing G-J; Harjola V-P; Huisman MV; Humbert M; Jennings CS; Jiménez D; Kucher N; Lang IM; Lankeit M; Lorusso R; Mazzolai L; Meneveau N; Ní Áinle F; Prandoni P; Pruszczyk P; Righini M; Torbicki A; Van Belle E; Zamorano JL; ESC Scientific Document Group
Article: GERONTOLOGY. 2020;66(5):447-459
The Prospective Studies of Atherosclerosis (Proof-ATHERO) Consortium: Design and Rationale
Tschiderer L; Seekircher L; Klingenschmid G; Izzo R; Baldassarre D; Iglseder B; Calabresi L; Liu J; Price J; Bae J-H; Brouwers F; de Groot E; Schmidt C; Bergstroem G; Asci G; Gresele P; Okazaki S; Kapellas K; Landecho M; Sattar N; Agewall S; Zou Z-Y; Byrne CD; Nanayakkara PWB; Papagianni A; Witham MD; Bernal E; Ekart R; van Agtmael MA; Neves MF; Sato E; Ezhov M; Walters M; Olsen MH; Stolic R; Zozulinska-Ziolkiewicz D; Hanefeld M; Staub D; Nagai M; Nieuwkerk PT; Huisman MV; Kato A; Honda H; Parraga G; Magliano D; Gabriel R; Rundek T; Espeland MA; Kiechl S; Willeit J; Lind L; Empana JP; Lonn E; Tuomainen T-P; Catapano A; Chien K-L; Sander D; Kavousi M; Beulens JWJ; Bots ML; Sweeting MJ; Lorenz MW; Willeit P
Article: AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(6):e671-e678
All-Cause Mortality and Cardiovascular Outcomes With Non-Vitamin K Oral Anticoagulants Versus Warfarin in Patients With Heart Failure in the Food and Drug Administration Adverse Event Reporting System
von Lueder TG; Atar D; Agewall S; Jensen JK; Hopper I; Kotecha D; Mentz RJ; Kim MH; Serebruany VL
Article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2019;5(4):210-215
Mortality and adverse events with brand and generic clopidogrel in the US Food and Drug Administration Adverse Event Reporting System
Serebruany VL; Hall TS; Atar D; Agewall S; Kim MH; Geudelin B; Lomakin N; Marciniak TA
Article: EUROPEAN RESPIRATORY JOURNAL. 2019;54(3):1901647
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC).
Konstantinides SV; Meyer G; Becattini C; Bueno H; Geersing G-J; Harjola V-P; Huisman MV; Humbert M; Jennings CS; Jiménez D; Kucher N; Lang IM; Lankeit M; Lorusso R; Mazzolai L; Meneveau N; Áinle FN; Prandoni P; Pruszczyk P; Righini M; Torbicki A; Van Belle E; Zamorano JL; The Task Force for the diagnosis and management of
Article: AMERICAN HEART JOURNAL. 2019;215:83-90
Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction
Hall TS; von Lueder TG; Zannad F; Rossignol P; Duarte K; Chouihed T; Solomon SD; Dickstein K; Atar D; Agewall S; Girerd N
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2019;289:83-90
Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis
Taeger T; Froehlich H; Grundtvig M; Seiz M; Schellberg D; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L
Article: CLINICAL CHEMISTRY. 2019;65(8):1023-1030
Increased Inflammatory Activity in Patients 3 Months after Myocardial Infarction with Nonobstructive Coronary Arteries
Hjort M; Eggers KM; Lindhagen L; Agewall S; Brolin EB; Collste O; Daniel M; Ekenback C; Frick M; Henareh L; Hofman-Bang C; Malmqvist K; Spaak J; Sorensson P; Y-Hassan S; Tornvall P; Lindahl B
Article: HEART. 2019;105(16):1252-1259
Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe
Froehlich H; Rosenfeld N; Taeger T; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L; Grundtvig M
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2019;287:128-131
ST-segment elevation and cardiac magnetic resonance imaging findings in myocardial infarction with non-obstructive coronary arteries
Hausvater A; Pasupathy S; Tornvall P; Gandhi H; Tavella R; Beltrame J; Agewall S; Ekenback C; Brolin EB; Hochman JS; Collste O; Reynolds HR
Article: CIRCULATION. 2019;139(18):e891-e908
Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association
Tamis-Holland JE; Jneid H; Reynolds HR; Agewall S; Brilakis ES; Brown TM; Lerman A; Cushman M; Kumbhani DJ; Arslanian-Engoren C; Bolger AF; Beltrame JF
Article: AMERICAN JOURNAL OF MEDICINE. 2019;132(3):374-381.e1
Personality Traits in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries
Nero D; Agewall S; Daniel M; Caidahl K; Collste O; Ekenback C; Frick M; Henareh L; Jernberg T; Malmqvist K; Schenck-Gustafsson K; Spaak J; Sorensson P; Sundin O; Y-Hassan S; Hofman-Bang C; Tornvall P
Article: EUROINTERVENTION. 2019;14(14):1435-1534
2018 ESC/EACTS Guidelines on myocardial revascularization
Neumann F-J; Sousa-Uva M; Ahlsson A; Alfonso F; Banning AP; Benedetto U; Byrne RA; Collet J-P; Falk V; Head SJ; Juni P; Kastrati A; Koller A; Kristensen SD; Niebauer J; Richter DJ; Seferovic PM; Sibbing D; Stefanini GG; Windecker S; Yadav R; Zembala MO
Article: EUROPEAN HEART JOURNAL. 2019;40(7):572
EHJ Cardiovascular Pharmacotherapy has Impact Factor.
Agewall S
Article: EUROPEAN HEART JOURNAL SUPPLEMENTS. 2019;21(A):A28-A33
Pharmacology of new treatments for hyperkalaemia: patiromer and sodium zirconium cyclosilicate
Rosano GMC; Spoletini I; Agewall S
Article: EUROPEAN HEART JOURNAL. 2019;40(2):87-165
2018 ESC/EACTS Guidelines on myocardial revascularization
Neumann F-J; Chettibi M; Sisakia H; Metzler B; Ibrahimov F; Stelmashok VI; Postadzhiyan A; Skoric B; Eftychiou C; Kala P; Terkelsen CJ; Magdy A; Eha J; Niemela M; Kedev S; Motreff P; Aladashvili A; Mehilli J; Kanakakis I-G; Becker D; Peace A; Romeo F; Bajraktari G; Kerimkulova A; Rudzitis A; Ghazzal Z; Kibarskis A; Xuereb RG; Hofma SH; Steigen TK; Witkowski A; de Oliveira EI; Mot S; Duplyakov D; Zavatta M; Beleslin B; Kovar F; Bunc M; Ojeda S; Witt N; Jeger R; Addad F; Akdemir R; Parkhomenko A; Henderson R; Pagano D; Freemantle N; Sousa-Uva M; Ahlsson A; Alfonso F; Banning AP; Benedetto U; Byrne RA; Collet J-P; Falk V; Head SJ; Juni P; Kastrati A; Koller A; Kristensen SD; Niebauer J; Richter DJ; Seferovic PM; Sibbing D; Stefanini GG; Windecker S; Yadav R; Zembala MO
Article: KARDIOLOGIA POLSKA. 2019;77(2):71-159
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams B; Mancia G; Spiering W; Rosei EA; Azizi M; Burnier M; Clement DL; Coca A; de Simone G; Dominiczak A; Kahan T; Mahfoud F; Redon J; Ruilope L; Zanchetti A; Kerins M; Kjeldsen SE; Kreutz R; Laurent S; Lip GYH; McManus R; Narkiewicz K; Ruschitzka F; Schmieder RE; Shlyakhto E; Tsioufis C; Aboyans V; Desormais I; Windecker S; Agewall S; Barbato E; Bueno H; Collet J-P; Coman IM; Dean V; Delgado V; Fitzsimons D; Gaemperli O; Hindricks G; Iung B; Juni P; Katus HA; Knuuti J; Lancellotti P; Leclercq C; McDonagh TA; Piepoli MF; Ponikowski P; Richter DJ; Roffi M; Simpson IA; Sousa-Uva M; Zamorano JL; Lurbe E; Bochud M; Jelakovic B; Januszewicz A; Polonia J; van de Borne P; Borghi C; Parati G; Manolis A; Lovic D
Article: EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. 2019;55(1):4-90
2018 ESC/EACTS Guidelines on myocardial revascularization
Sousa-Uva M; Neumann F-J; Ahlsson A; Alfonso F; Banning AP; Benedetto U; Byrne RA; Collet J-P; Falk V; Head SJ; Juni P; Kastrati A; Koller A; Kristensen SD; Niebauer J; Richter DJ; Seferovic PM; Sibbing D; Stefanini GG; Windecker S; Yadav R; Zembala MO
Article: PLOS ONE. 2019;14(7):e0220079
Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study
Hokstad I; Deyab G; Fagerland MW; Lyberg T; Hjeltnes G; Forre O; Agewall S; Mollnes TE; Hollan I
Journal article: REVISTA ESPANOLA DE CARDIOLOGIA. 2019;72(1):237-269
Fourth universal definition of myocardial infarction (2018)
Thygesen K; Alpert JS; Jaffe AS; Chaitman BR; Bax JJ; Morrow DA; White HD; Mickley H; Crea F; Van de Werf F; Bucciarelli-Ducci C; Katus HA; Pinto FJ; Antman EM; Hamm CW; de Caterina R; Underwood SR; Canty JMJ; Lyon AR; Devereaux PJ; Luis Zamorano J; Lindahl B; Weintraub WS; Newby LK; Virmani R; Vranckx P; Cutlip D; Gibbons RJ; Smith SC; Atar D; Luepker RV; Robertson RM; Bonow RO; Steg PG; O'Gara PT; Fox KAA
Article: REVISTA ESPANOLA DE CARDIOLOGIA. 2019;72(1):151-226
2018 ESC/EACTS Guidelines on myocardial revascularization
Neumann F-J; Sousa-Uva M; Ahlsson A; Alfonso F; Banning AP; Benedetto U; Byrne RA; Collet J-P; Falk V; Head SJ; Juni P; Kastrati A; Koller A; Kristensen SD; Niebauer J; Richter DJ; Seferovic PM; Sibbing D; Stefanini GG; Windecker S; Yadav R; Zembala MO; Wijns W; Glineur D; Aboyans V; Achenbach S; Agewall S; Andreotti F; Barbato E; Baumbach A; Brophy J; Bueno H; Calvert PA; Capodanno D; Davierwala PM; Delgado V; Dudek D; Freemantle N; Funck-Brentano C; Gaemperli O; Gielen S; Gilard M; Gorenek B; Haasenritter J; Haude M; Ibanez B; Lung B; Jeppsson A; Katritsis D; Knuuti J; Kolh P; Leite-Moreira A; Lund LH; Maisano F; Mehilli J; Metzler B; Montalescot G; Pagano D; Petronio AS; Piepoli MF; Popescu BA; Sadaba R; Shlyakhto E; Silber S; Simpson LA; Spary D; Tavilla G; Thiele H; Tousek P; Van Belle E; Vranckx P; Witkowski A; Zamorano JL; Roffi M
Article: REVISTA ESPANOLA DE CARDIOLOGIA. 2018;71(10):837.e1-837.e92
2018 ESC Guidelines for the diagnosis and management of syncope
Brignole M; Moya A; de lange FJ; Deharo J-C; Elliott PM; Fanciulli A; Fedorowski A; Furlan R; Kenny RA; Martin A; Probst V; Reed MJ; Rice CP; Sutton R; Ungar A; van Dijk JG; Torbicki A; Moreno J; Aboyans V; Agewall S; Asteggiano R; Blanc J-J; Bornstein N; Boveda S; Bueno H; Burri H; Coca A; Collet J-P; Costantino G; Diaz-Infante E; Delgado V; Dolmans F; Gaemperli O; Gajek J; Hindricks G; Kautzner J; Knuuti J; Kulakowski P; Lambrinou E; Leclercq C; Mabo P; Morillo CA; Piepoli MF; Roffi M; Shen WK; Simpson IA; Stockburger M; Vanbrabant P; Windecker S; Luis Zamorano J
Article: EUROPEAN HEART JOURNAL. 2018;39(34):3165-3241
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.
Regitz-Zagrosek V; Roos-Hesselink JW; Bauersachs J; Blomström-Lundqvist C; Cífková R; De Bonis M; Iung B; Johnson MR; Kintscher U; Kranke P; Lang IM; Morais J; Pieper PG; Presbitero P; Price S; Rosano GMC; Seeland U; Simoncini T; Swan L; Warnes CA; ESC Scientific Document Group
Article: AMERICAN JOURNAL OF MEDICINE. 2018;131(9):1118-1124
Prevalence of Anxiety and Depression Symptoms in Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries
Daniel M; Agewall S; Berglund F; Caidahl K; Collste O; Ekenback C; Frick M; Henareh L; Jernberg T; Malmqvist K; Schenck-Gustafsson K; Spaak J; Sundin O; Sorensson P; Y-Hassan S; Hofman-Bang C; Tornvall P
Article: JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY. 2018;49:91-97
Effect of anti-rheumatic treatment on selenium levels in inflammatory arthritis
Deyab G; Hokstad I; Aaseth J; Smastuen MC; Whist JE; Agewall S; Lyberg T; Tveiten D; Hjeltnes G; Zibara K; Hollan I
Journal article: EUROPEAN HEART JOURNAL. 2018;39(suppl_1):ehy566.p6392
P6392Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction
Hall TS; Von Lueder TG; Zannad F; Rossignol P; Duarte K; Chouihed T; Dickstein K; Atar D; Agewall S; Girerd N
Journal article: EUROPEAN HEART JOURNAL. 2018;39(suppl_1):ehy565.p1814
P1814Deaths and vascular outcomes with non-vitamin K oral anticoagulants versus warfarin in patients with heart failure in the food and drug administration adverse event reporting system
Von Lueder TA; Atar D; Agewall S; Jensen J; Hopper I; Kotecha D; Mentz R; Serebruany VL
Article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2018;4(3):180-188
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology
Rosano GMC; Tamargo J; Kjeldsen KP; Lainscak M; Agewall S; Anker SD; Ceconi C; Coats AJS; Drexel H; Filippatos G; Kaski JC; Lund L; Niessner A; Ponikowski P; Savarese G; Schmidt TA; Seferovic P; Wassmann S; Walther T; Lewis BS
Article: EUROPEAN HEART JOURNAL. 2018;39(24):2274-2281
Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Niessner A; Tamargo J; Koller L; Saely CH; Schmidt TA; Savarese G; Wassmann S; Rosano G; Ceconi C; Torp-Pedersen C; Kaski JC; Kjeldsen KP; Agewall S; Walther T; Drexel H; Lewis BS
Journal article: EUROPEAN HEART JOURNAL. 2018;39(21):1980
2017 ESC/EACTS Guidelines for the management of valvular heart disease (vol 38, pg 2739, 2017)
Baumgartner H; Falk V; Bax JJ; De Bonis M; Hamm C; Holm PJ; Iung B; Lancellotti P; Lansac E; Raphael Rosenhek DRM; Sjogren J; Mas PT; Vahanian A; Walther T; Wendler O; Windecker S; Zamorano JL
Article: EUROPEAN HEART JOURNAL. 2018;39(21):1883-1948
2018 ESC Guidelines for the diagnosis and management of syncope
Brignole M; Moya A; de lange FJ; Deharo J-C; Elliott PM; Fanciulli A; Fedorowski A; Furlan R; Kenny RA; Martin A; Probst V; Reed MJ; Rice CP; Sutton R; Ungar A; van Dijk JG
Article: EUROPEAN HEART JOURNAL. 2018;39(21):e43-e80
Practical Instructions for the 2018 ESC Guidelines for the diagnosis and management of syncope
Brignole M; Moya A; de lange FJ; Deharo J-C; Elliott PM; Fanciulli A; Fedorowski A; Furlan R; Kenny RA; Martin A; Probst V; Reed MJ; Rice CP; Sutton R; Ungar A; van Dijk JG
Article: EUROPACE. 2018;20(5):731-732an
Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)
Dan G-A; Martinez-Rubio A; Agewall S; Boriani G; Borggrefe M; Gaita F; van Gelder I; Gorenek B; Kaski JC; Kjeldsen K; Lip GYH; Merkely B; Okumura K; Piccini JP; Potpara T; Poulsen BK; Saba M; Savelieva I; Tamargo JL; Wolpert C
Article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2018;4(2):82-92
Comparative effectiveness of enalapril, lisinopril, and ramipril in the treatment of patients with chronic heart failure: a propensity score-matched cohort study
Froehlich H; Henning F; Taeger T; Schellberg D; Grundtvig M; Goode K; Corletto A; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Frankenstein L; Clark AL
Article: EUROPEAN HEART JOURNAL. 2018;39(9):763-816
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
Aboyans V; Ricco J-B; Bartelink M-LEL; Bjorck M; Brodmann M; Cohnert T; Collet J-P; Czerny M; De Carlo M; Debus S; Espinola-Klein C; Kahan T; Kownator S; Mazzolai L; Naylor AR; Roffi M; Roether J; Sprynger M; Tendera M; Tepe G; Venermo M; Vlachopoulos C; Desormais I
Article: EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY. 2018;55(3):305-368
Editor's Choice-2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
Aboyans V; Ricco J-B; Bartelink M-LEL; Bjorck M; Brodmann M; Cohnert T; Collet J-P; Czerny M; De Carlo M; Debus S; Espinola-Klein C; Kahan T; Kownator S; Mazzolai L; Naylor AR; Roffi M; Roether J; Sprynger M; Tendera M; Tepe G; Venermo M; Vlachopoulos C; Desormais I; Widimsky P; Kolh P; Agewall S; Bueno H; Coca A; De Borst GJ; Delgado V; Dick F; Erol C; Ferrini M; Kakkos S; Katus HA; Knuuti J; Lindholt J; Mattle H; Pieniazek P; Piepoli MF; Scheinert D; Sievert H; Simpson I; Sulzenko J; Tamargo J; Tokgozoglu L; Torbicki A; Tsakountakis N; Tunon J; Vega de Ceniga M; Windecker S; Zamorano JL
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2018;38(2):246-253
Plasma biomarker levels and non-obstructive coronary artery disease determined by coronary computed tomography angiography
Brolin EB; Agewall S; Cederlund K; Ekenback C; Henareh L; Malmqvist K; Ruck A; Svensson A; Tornvall P
Article: EUROPEAN HEART JOURNAL. 2018;39(3):213-260
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
Valgimigli M; Bueno H; Byrne RA; Collet J-P; Costa F; Jeppsson A; Juni P; Kastrati A; Kolh P; Mauri L; Montalescot G; Neumann F-J; Petricevic M; Roffi M; Steg PG; Windecker S; Luis Zamorano J; Levine GN; Badimon L; Vranckx P; Agewall S; Andreotti F; Antman E; Barbato E; Bassand J-P; Bugiardini R; Cikirikcioglu M; Cuisset T; De Bonis M; Delgado V; Fitzsimons D; Oliver G; Galie N; Gilard M; Hamm CW; Ibanez B; Iung B; James S; Knuuti J; Landmesser U; Leclercq C; Lettino M; Lip G; Piepoli MF; Pierard L; Schwerzmann M; Sechtem U; Simpson IA; Uva MS; Stabile E; Storey RF; Tendera M; Van de Werf F; Verheugt F; Aboyans V
Article: EUROPEAN HEART JOURNAL. 2018;39(3):e1-e33
Case-based implementation of the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease.
Collet J-P; Roffi M; Byrne RA; Costa F; Valgimigli M; Task Force for the Management of Dual Antiplatelet; ESC Scientific Document Group; Task Force for the Management of Dual Antiplatelet
Article: EUROPEAN HEART JOURNAL. 2018;39(2):119-177
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)
Ibanez B; James S; Agewall S; Antunes MJ; Bucciarelli-Ducci C; Bueno H; Caforio ALP; Crea F; Goudevenos JA; Halvorsen S; Hindricks G; Kastrati A; Lenzen MJ; Prescott E; Roffi M; Valgimigli M; Varenhorst C; Vranckx P; Widimsky P; Collet J-P; Kristensen SD; Aboyans V; Baumbach A; Bugiardini R; Coman IM; Delgado V; Fitzsimons D; Gaemperli O; Gershlick AH; Gielen S; Harjola V-P; Katus HA; Knuuti J; Kolh P; Leclercq C; Lip GYH; Morais J; Neskovic AN; Neumann F-J; Niessner A; Piepoli MF; Richter DJ; Shlyakhto E; Simpson IA; Steg PG; Terkelsen CJ; Thygesen K; Windecker S; Zamorano JL; Zeymer U
Journal article: REVISTA ESPANOLA DE CARDIOLOGIA. 2018;71(1):42.e1-42.e58
Actualización ESC 2017 sobre el tratamiento antiagregante plaquetario doble en la enfermedad coronaria, desarrollada en colaboración con la EACTS
de Trabajo: Marco Valgimigli AMDG; Bueno H; Byrne RA; Collet J-P; Costa F; Jeppsson A; Jüni P; Kastrati A; Kolh P; Mauri L; Montalescot G; Neumann F-J; Petricevic M; Roffi M; Steg PG; Windecker S; Zamorano JL; Levine CAGN; del documento: Lina Badimon R; Vranckx P; Agewall S; Andreotti F; Antman E; Barbato E; Bassand J-P; Bugiardini R; Cikirikcioglu M; Cuisset T; De Bonis M; Delgado V; Fitzsimons D; Gaemperli O; Galiè N; Gilard M; Hamm CW; Ibáñez B; Iung B; James S; Knuuti J; Landmesser U; Leclercq C; Lettino M; Lip G; Piepoli MF; Pierard L; Schwerzmann M; Sechtem U; Simpson IA; Uva MS; Stabile E; Storey RF; Tendera M; Van de Werf F; Verheugt F; Aboyans V
Article: KARDIOLOGIA POLSKA. 2018;76(2):229-313
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
Ibanez B; James S; Agewall S; Antunes MJ; Bucciarelli-Ducci C; Bueno H; Caforio ALP; Crea F; Goudevenos JA; Halvorsen S; Hindricks G; Kastrati A; Lenzen MJ; Prescott E; Roffi M; Valgimigli M; Varenhorst C; Vranckx P; Widimsky P
Article: EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. 2018;53(1):34-78
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)
Valgimigli M; Bueno H; Byrne RA; Collet J-P; Costa F; Jeppsson A; Juni P; Kastrati A; Kolh P; Mauri L; Montalescot G; Neumann F-J; Petricevic M; Roffi M; Steg PG; Windecker S; Luis Zamorano J; Badimon L; Vranckx P; Agewall S; Andreotti F; Antman E; Barbato E; Bassand J-P; Bugiardini R; Cikirikcioglu M; Cuisset T; De Bonis M; Delgado V; Fitzsimons D; Gaemperli O; Galie N; Gilard M; Hamm CW; Ibanez B; Iung B; James S; Knuuti J; Landmesser U; Leclercq C; Lettino M; Lip G; Piepoli MF; Pierard L; Schwerzmann M; Sechtem U; Simpson IA; Uva MS; Stabile E; Storey RF; Tendera M; Van de Werf F; Verheugt F; Aboyans V
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2017;249:274-281
Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status an analysis from the high-risk myocardial infarction database initiative
Agewall S; Tjessem LH; Rossignol P; Zannad F; Atar D; Lamiral Z; Machu J-L; Dickstein K; Kjekshus J; von Lueder TG; Girerd N
Journal article: REVISTA ESPANOLA DE CARDIOLOGIA. 2017;70(12):1082.e1-1082.e61
Guía ESC 2017 sobre el tratamiento del infarto agudo de miocardio en pacientes con elevación del segmento ST
Ibáñez B; James S; Agewall S; Antunes MJ; Bucciarelli-Ducci C; Bueno H; Caforio ALP; Crea F; Goudevenos JA; Halvorsen S; Hindricks G; Kastrati A; Lenzen MJ; Prescott E; Roffi M; Valgimigli M; Varenhorst C; Vranckx P; Widimsk P; Collet J-P; Kristensen SD; Aboyans V; Baumbach A; Bugiardini R; Coman IM; Delgado V; Fitzsimons D; Gaemperli O; Gershlick AH; Gielen S; Harjola V-P; Katus HA; Knuuti J; Kolh P; Leclercq C; Lip GYH; Morais J; Neskovic AN; Neumann F-J; Niessner A; Piepoli MF; Richter DJ; Shlyakhto E; Simpson IA; Steg G; Terkelsen CJ; Thygesen K; Windecker S; Zamorano JL; Zeymer U
Article: REVISTA ESPANOLA DE CARDIOLOGIA. 2017;70(12):1082
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.
Ibánez B; James S; Agewall S; Antunes MJ; Bucciarelli-Ducci C; Bueno H; Caforio ALP; Crea F; Goudevenos JA; Halvorsen S; Hindricks G; Kastrati A; Lenzen MJ; Prescott E; Roffi M; Valgimigli M; Varenhorst C; Vranckx P; Widimský P
Article: ARTHRITIS RESEARCH & THERAPY. 2017;19(1):232
Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis
Deyab G; Hokstad I; Whist JE; Smastuen MC; Agewall S; Lyberg T; Ronda N; Mikkelsen K; Hjeltnes G; Hollan I
Article: EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. 2017;52(4):616-664
2017 ESC/EACTS Guidelines for the management of valvular heart disease
Falk V; Baumgartner H; Bax JJ; De Bonis M; Hamm C; Holm PJ; Iung B; Lancellotti P; Lansac E; Rodriguez Munoz D; Rosenhek R; Sjogren J; Tornos Mas P; Vahanian A; Walther T; Wendler O; Windecker S; Luis Zamorano J
Article: CLINICAL RESEARCH IN CARDIOLOGY. 2017;106(9):711-721
Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure
Froehlich H; Torres L; Taeger T; Schellberg D; Corletto A; Kazmi S; Goode K; Grundtvig M; Hole T; Katus HA; Cleland JGF; Atar D; Clark AL; Agewall S; Frankenstein L
Article: EUROPEAN HEART JOURNAL. 2017;38(32):2473-2479
Comprehensive efforts to increase adherence to statin therapy
Vonbank A; Agewall S; Kjeldsen KP; Lewis BS; Torp-Pedersen C; Ceconi C; Funck-Brentano C; Kaski JC; Niessner A; Tamargo J; Walther T; Wassmann S; Rosano G; Schmidt H; Saely CH; Drexel H
Journal article: EUROPEAN HEART JOURNAL. 2017;38(suppl_1):ehx504.p4392
P4392Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status
Agewall S; Tjessum L; Rossignol P; Zannad F; Atar D; Von Lueder T; Lamiral Z; Machu JL; Kjekshus J; Girerd N
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2017;120(3):341-346
Effect of Myocardial Infarction With Nonobstructive Coronary Arteries on Physical Capacity and Quality-of-Life
Daniel M; Agewall S; Caidahl K; Collste O; Ekenback C; Frick M; Y-Hassan S; Henareh L; Jernberg T; Malmqvist K; Schenck-Gustafsson K; Sorensson P; Sundin O; Hofman-Bang C; Tornvall P
Article: BMC CARDIOVASCULAR DISORDERS. 2017;17(1):199
The value of a new cardiac magnetic resonance imaging protocol in Myocardial Infarction with Non-obstructive Coronary Arteries (MINOCA) - a case-control study using historical controls from a previous study with similar inclusion criteria
Tornvall P; Brolin EB; Caidahl K; Cederlund K; Collste O; Daniel M; Ekenback C; Jensen J; Y-Hassan S; Henareh L; Hofman-Bang C; Lynga P; Maret E; Sarkar N; Spaak J; Sundqvist M; Sorensson P; Ugander M; Agewall S
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2017;238:97-104
Statins attenuate but do not eliminate the reverse epidemiology of total serum cholesterol in patients with non-ischemic chronic heart failure
Frohlich H; Raman N; Tager T; Schellberg D; Goode KM; Kazmi S; Grundtvig M; Hole T; Cleland JGF; Katus HA; Agewall S; Clark AL; Atar D; Frankenstein L
Article: GIORNALE ITALIANO DI CARDIOLOGIA. 2017;18(7):547-612
2016 European Guidelines on the Prevention of Cardiovascular Diseases in Clinical Practice Sixth Joint Task Force of the European Society of Cardiology and other Societies on the Prevention of Cardiovascular Diseases in Clinical Practice (consisting of representatives of 10 companies and invited experts) drafted with the extraordinary contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR)
Piepoli MF; Hoes AW; Agewall S; Albus C; Brotons C; Catapano AL; Cooney M-T; Corra U; Cosyns B; Deaton C; Graham I; Hall MS; Hobbs FDR; Lochen M-L; Lollgen H; Marques-Vidal P; Perk J; Prescott E; Redon J; Richter DJ; Sattar N; Smulders Y; Tiberi M; van der Worp HB; van Dis I; Verschuren WMM; Binno S; De Backer G; Roffi M; Aboyans V; Bachl N; Bueno H; Carerj S; Cho L; Cox J; De Sutter J; Egidi G; Fisher M; Fitzsimons D; Franco OH; Guenoun M; Jennings C; Jug B; Kirchhof P; Kotseva K; Lip GYH; Mach F; Mancia G; Bermudo FM; Mezzani A; Niessner A; Ponikowski P; Rauch B; Ryden L; Stauder A; Turc G; Wiklund O; Windecker S; Luis Zamorano J
Article: EUROPEAN HEART JOURNAL. 2017;38(22):1710-1716
Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis
Niessner A; Tamargo J; Morais J; Koller L; Wassmann S; Husted SE; Torp-Pedersen C; Kjeldsen K; Lewis BS; Drexel H; Kaski JC; Atar D; Storey RF; Lip GYH; Verheugt FWA; Agewall S
Article: INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE. 2017;24(3):321-419
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli MF; Hoes AW; Agewall S; Albus C; Brotons C; Catapano AL; Cooney M-T; Corra U; Cosyns B; Deaton C; Graham I; Hall MS; Hobbs FDR; Lochen M-L; Loellgen H; Marques-Vidal P; Perk J; Prescott E; Redon J; Richter DJ; Sattar N; Smulders Y; Tiberi M; van der Worp HB; van Dis I; Verschuren WMM
Article: BMC MEDICAL INFORMATICS AND DECISION MAKING. 2017;17(1):40
Automatic identification of variables in epidemiological datasets using logic regression
Lorenz MW; Abdi NA; Scheckenbach F; Pflug A; Buelbuel A; Catapano AL; Agewall S; Ezhov M; Bots ML; Kiechl S; Orth A
Journal article: REVISTA ESPANOLA DE CARDIOLOGIA. 2017;70(2):115.e1-115.e64
Guía ESC/EAS 2016 sobre el tratamiento de las dislipemias
de las Dislipemias GDTDLSE; de la European Association for Cardiovascular Prev DCLCE; de Trabajo AMDG; Catapano AL; Graham I; De Backer G; Wiklund O; Chapman MJ; Drexel H; Hoes AW; Jennings CS; Landmesser U; Pedersen TR; Reiner Ž; Riccardi G; Taskinen M-R; Tokgozoglu L; Verschuren WMM; Vlachopoulos C; Wood DA; Zamorano JL; adicional C; Cooney M-T; del documento R; Badimon L; Funck-Brentano C; Agewall S; Barón-Esquivias G; Borén J; Bruckert E; Cordero A; Corsini A; Giannuzzi P; Gueyffier F; Krstačić G; Lettino M; Lionis C; Lip GYH; Marques-Vidal P; Milicic D; Pedro-Botet J; Piepoli MF; Rigopoulos AG; Ruschitzka F; Tuñón J; von Eckardstein A; Vrablik M; Weiss TW; Williams B; Windecker S; Zimlichman R
Article: EUROPACE. 2017;19(2):190-225
European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS)
Gorenek B; Pelliccia A; Benjamin EJ; Boriani G; Crijns HJ; Fogel RI; Van Gelder IC; Halle M; Kudaiberdieva G; Lane DA; Larsen TB; Lip GYH; Lochen M-L; Marin F; Niebauer J; Sanders P; Tokgozoglu L; Vos MA; Van Wagoner DR; Fauchier L; Savelieva I; Goette A; Agewall S; Chiang C-E; Figueiredo M; Stiles M; Dickfeld T; Patton K; Piepoli M; Corra U; Marques-Vidal PM; Faggiano P; Schmid J-P; Abreu A
Article: EUROPEAN HEART JOURNAL. 2017;38(3):143-153
ESC working group position paper on myocardial infarction with non-obstructive coronary arteries
Agewall S; Beltrame JF; Reynolds HR; Niessner A; Rosano G; Caforio ALP; De Caterina R; Zimarino M; Roffi M; Kjeldsen K; Atar D; Kaski JC; Sechtem U; Tornvall P
Article: PLOS ONE. 2017;12(2):e0169830
Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
Deyab G; Hokstad I; Whist JE; Smastuen MC; Agewall S; Lyberg T; Bottazzi B; Meroni PL; Leone R; Hjeltnes G; Hollan I
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2017;19(1):9-42
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)
Luis Zamorano J; Lancellotti P; Rodriguez Munoz D; Aboyans V; Asteggiano R; Galderisi M; Habib G; Lenihan DJ; Lip GYH; Lyon AR; Lopez Fernandez T; Mohty D; Piepoli MF; Tamargo J; Torbicki A; Suter TM; Achenbach S; Agewall S; Badimon L; Baron-Esquivias G; Baumgartner H; Bax JJ; Bueno H; Carerj S; Dean V; Erol C; Fitzsimons D; Gaemperli O; Kirchhof P; Kolh P; Lancellotti P; Nihoyannopoulos P; Ponikowski P; Roffi M; Carneiro AV; Windecker S; Minotti G; Cardinale D; de Azambuja E; Dent S; Erol C; Ewer MS; Farmakis D; Fietkau R; Fitzsimons D; McGale P; Ringwald J
Article: REVISTA ESPANOLA DE CARDIOLOGIA. 2017;18(11):50-1678
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof P; Benussi S; Kotecha D; Ahlsson A; Atar D; Casadei B; Castella M; Diener H-C; Heidbuchel H; Hendriks J; Hindricks G; Manolis AS; Oldgren J; Popescu BA; Schotten U; Van Putte B; Vardas P; Agewall S; Camm J; Baron Esquivias G; Budts W; Carerj S; Casselman F; Coca A; De Caterina R; Deftereos S; Dobrev D; Ferro JM; Filippatos G; Fitzsimons D; Gorenek B; Guenoun M; Hohnloser SH; Kolh P; Lip GYH; Manolis A; McMurray J; Ponikowski P; Rosenhek R; Ruschitzka F; Savelieva I; Sharma S; Suwalski P; Luis Tamargo J; Taylor CJ; Van Gelder IC; Voors AA; Windecker S; Luis Zamorano J; Zeppenfeld K
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2017;24(1):4-40
European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS)
Gorenek B; Pelliccia A; Benjamin EJ; Boriani G; Crijns HJ; Fogel RI; Van Gelder IC; Halle M; Kudaiberdieva G; Lane DA; Larsen TB; Lip GYH; Lochen M-L; Marin F; Niebauer J; Sanders P; Tokgozoglu L; Vos MA; Van Wagoner DR; Fauchier L; Savelieva I; Goette A; Agewall S; Chiang C-E; Figueiredo M; Stiles M; Dickfeld T; Patton K; Piepoli M; Corra U; Marques-Vidal PM; Faggiano P; Schmid J-P; Abreu A
Article: REVISTA ESPANOLA DE CARDIOLOGIA. 2017;70(1):50.e1-50.e84
2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS
Kirchhof P; Benussi S; Kotecha D; Ahlsson A; Atar D; Casadei B; Castella M; Diener H-C; Heidbuchel H; Hendriks J; Hindricks G; Manolis AS; Oldgren J; Popescu BA; Schotten U; Van Putte B; Vardas P
Journal article: REVISTA ESPANOLA DE CARDIOLOGIA. 2016;69(12):1167.e1-1167.e85
Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica
de la ESC GDTDLSE; de Trabajo: Piotr Ponikowski AMDG; Voors AA; Anker SD; Bueno H; Cleland JGF; Coats AJS; Falk V; González-Juanatey JR; Harjola V-P; Jankowska EA; Jessup M; Linde C; Nihoyannopoulos P; Parissis JT; Pieske B; Riley JP; Rosano GMC; Ruilope LM; Ruschitzka F; Rutten FH; van der Meer P; del documento: Gerasimos Filippatos R; McMurray JJV; Aboyans V; Achenbach S; Agewall S; Al-Attar N; Atherton JJ; Bauersachs J; Camm AJ; Carerj S; Ceconi C; Coca A; Elliott P; Erol Ç; Ezekowitz J; Fernández-Golfín C; Fitzsimons D; Guazzi M; Guenoun M; Hasenfuss G; Hindricks G; Hoes AW; Iung B; Jaarsma T; Kirchhof P; Knuuti J; Kolh P; Konstantinides S; Lainscak M; Lancellotti P; Lip GYH; Maisano F; Mueller C; Petrie MC; Piepoli MF; Priori SG; Torbicki A; Tsutsui H; van Veldhuisen DJ; Windecker S; Yancy C; Zamorano JL
Article: EUROPACE. 2016;18(11):1609-1678
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
Kirchhof P; Benussi S; Kotecha D; Ahlsson A; Atar D; Casadei B; Castella M; Diener H-C; Heidbuchel H; Hendriks J; Hindricks G; Manolis AS; Oldgren J; Popescu BA; Schotten U; Van Putte B; Vardas P; Agewall S; Camm J; Baron Esquivias G; Budts W; Carerj S; Casselman F; Coca A; De Caterina R; Deftereos S; Dobrev D; Ferro JM; Filippatos G; Fitzsimons D; Gorenek B; Guenoun M; Hohnloser SH; Kolh P; Lip GYH; Manolis A; McMurray J; Ponikowski P; Rosenhek R; Ruschitzka F; Savelieva I; Sharma S; Suwalski P; Tamargo JL; Taylor CJ; Van Gelder IC; Voors AA; Windecker S; Zamorano JL; Zeppenfeld K
Article: EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. 2016;50(5):e1-e88
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
Kirchhof P; Benussi S; Kotecha D; Ahlsson A; Atar D; Casadei B; Castella M; Diener H-C; Heidbuchel H; Hendriks J; Hindricks G; Manolis AS; Oldgren J; Popescu BA; Schotten U; Van Putte B; Vardas P; Agewall S; Camm J; Baron Esquivias G; Budts W; Carerj S; Casselman F; Coca A; De Caterina R; Deftereos S; Dobrev D; Ferro JM; Filippatos G; Fitzsimons D; Gorenek B; Guenoun M; Hohnloser SH; Kolh P; Lip GYH; Manolis A; McMurray J; Ponikowski P; Rosenhek R; Ruschitzka F; Savelieva I; Sharma S; Suwalski P; Tamargo JL; Taylor CJ; Van Gelder IC; Voors AA; Windecker S; Zamorano JL; Zeppenfeld K
Article: LAKARTIDNINGEN. 2016;113:D7HM
[A healthy lifestyle in focus of new guidelines].
Perk J; Agewall S; Kiessling A
Article: EUROPEAN HEART JOURNAL. 2016;37(39):2999-3058
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.
Catapano AL; Graham I; De Backer G; Wiklund O; Chapman MJ; Drexel H; Hoes AW; Jennings CS; Landmesser U; Pedersen TR; Reiner Ž; Riccardi G; Taskinen M-R; Tokgozoglu L; Verschuren WMM; Vlachopoulos C; Wood DA; Zamorano JL; Cooney M-T; ESC Scientific Document Group
Article: EUROPEAN HEART JOURNAL. 2016;37(38):2893-2962
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof P; Benussi S; Kotecha D; Ahlsson A; Atar D; Casadei B; Castella M; Diener H-C; Heidbuchel H; Hendriks J; Hindricks G; Manolis AS; Oldgren J; Popescu BA; Schotten U; Van Putte B; Vardas P
Journal article: REVISTA ESPANOLA DE CARDIOLOGIA. 2016;69(10):939.e1-939.e87
Guía ESC 2016 sobre prevención de la enfermedad cardiovascular en la práctica clínica
de la European Association for Cardiovascular Prev SGDTCDL; de trabajo: Massimo F. Piepoli AMDG; Hoes AW; Agewall S; Albus C; Brotons C; Catapano AL; Cooney M-T; Corrà U; Cosyns B; Deaton C; Graham I; Hall MS; Hobbs FDR; Løchen M-L; Löllgen H; Marques-Vidal P; Perk J; Prescott E; Redon J; Richter DJ; Sattar N; Smulders Y; Tiberi M; van der Worp HB; van Dis I; Verschuren WMM; Binno CAS; De Backer RDDG; Roffi M; Aboyans V; Bachl N; Bueno H; Carerj S; Cho L; Cox J; De Sutter J; Egidi G; Fisher M; Fitzsimons D; Franco OH; Guenoun M; Jennings C; Jug B; Kirchhof P; Kotseva K; Lip GYH; Mach F; Mancia G; Bermudo FM; Mezzani A; Niessner A; Ponikowski P; Rauch B; Rydén L; Stauder A; Turc G; Wiklund O; Windecker S; Zamorano JL
Article: REVISTA ESPANOLA DE CARDIOLOGIA. 2016;69(10):939
2016 European Guidelines on cardiovascular disease prevention in clinical practice.
Piepoli MF; Hoes AW; Agewall S; Albus C; Brotons C; Catapano AL; Cooney M-T; Corrà U; Cosyns B; Deaton C; Graham I; Hall MS; Richard Hobbs FD; Løchen M-L; Löllgen H; Marques-Vidal P; Perk J; Prescott E; Redon J; Richter DJ; Sattar N; Smulders Y; Tiberi M; Bart van der Worp H; van Dis I; Monique Verschuren WM
Article: EUROPEAN HEART JOURNAL. 2016;37(36):2768-2801
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
Zamorano JL; Lancellotti P; Munoz DR; Aboyans V; Asteggiano R; Galderisi M; Habib G; Lenihan DJ; Lip GYH; Lyon AR; Lopez Fernandez T; Mohty D; Piepoli MF; Tamargo J; Torbicki A; Suter TM; Zamorano JL; Aboyans V; Achenbach S; Agewall S; Badimon L; Baron-Esquivias G; Baumgartner H; Bax JJ; Bueno H; Carerj S; Dean V; Erol C; Fitzsimons D; Gaemperli O; Kirchhof P; Kolh P; Lancellotti P; Lip GYH; Nihoyannopoulos P; Piepoli MF; Ponikowski P; Roffi M; Torbicki A; Carneiro AV; Windecker S; Achenbach S; Minotti G; Agewall S; Badimon L; Bueno H; Cardinale D; Carerj S; Curigliano G; de Azambuja E; Dent S; Erol C; Ewer MS; Farmakis D; Fietkau R; Fitzsimons D; Gaemperli O; Kirchhof P; Kohl P; McGale P; Ponikowski P; Ringwald J; Roffi M; Schulz-Menger J; Stebbing J; Steiner RK; Szmit S; Carneiro AV; Windecker S
Article: ATHEROSCLEROSIS. 2016;252:207-274
2016 European Guidelines on cardiovascular disease prevention in clinical practice The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
Piepoli MF; Hoes AW; Agewall S; Albus C; Brotons C; Catapano AL; Cooney M-T; Corra U; Cosyns B; Deaton C; Graham I; Hall MS; Hobbs FDR; Lochen M-L; Loellgen H; Marques-Vidal P; Perk J; Prescott E; Redon J; Richter DJ; Sattar N; Smulders Y; Tiberi M; van der Worp HB; van Dis I; Verschuren WMM
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2016;18(8):891-975
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
Ponikowski P; Voors AA; Anker SD; Bueno H; Cleland JGF; Coats AJS; Falk V; Gonzalez-Juanatey JR; Harjola V-P; Jankowska EA; Jessup M; Linde C; Nihoyannopoulos P; Parissis JT; Pieske B; Riley JP; Rosano GMC; Ruilope LM; Ruschitzka F; Rutten FH; van der Meer P; Filippatos G; McMurray JJV; Aboyans V; Achenbach S; Agewall S; Al-Attar N; Atherton JJ; Bauersachs J; Camm AJ; Carerj S; Ceconi C; Coca A; Elliott P; Erol C; Ezekowitz J; Fernandez-Golfin C; Fitzsimons D; Guazzi M
Article: EUROPEAN HEART JOURNAL. 2016;37(29):2315-2381
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli MF; Hoes AW; Agewall S; Albus C; Brotons C; Catapano AL; Cooney M-T; Corra U; Cosyns B; Deaton C; Graham I; Hall MS; Hobbs FDR; Lochen M-L; Loellgen H; Marques-Vidal P; Perk J; Prescott E; Redon J; Richter DJ; Sattar N; Smulders Y; Tiberi M; van der Worp HB; van Dis I; Verschuren WMM
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2016;23(11):NP1-NP96
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)
Piepoli MF; Hoes AW; Agewall S; Albus C; Brotons C; Catapano AL; Cooney M-T; Corra U; Cosyns B; Deaton C; Graham I; Hall MS; Hobbs FDR; Lochen M-L; Loellgen H; Marques-Vidal P; Perk J; Prescott E; Redon J; Richter DJ; Sattar N; Smulders Y; Tiberi M; van der Worp HB; van Dis I; Verschuren WMM; De Backer G; Roffi M; Aboyans V; Bachl N; Bueno H; Carerj S; Cho L; Cox J; De Sutter J; Egidi G; Fisher M; Fitzsimons D; Franco OH; Guenoun M; Jennings C; Jug B; Kirchhof P; Kotseva K; Lip GYH; Mach F; Mancia G; Bermudo FM; Mezzani A; Niessner A; Ponikowski P; Rauch B; Ryden L; Stauder A; Turc G; Wiklund O; Windecker S; Zamorano JL
Article: INTERNATIONAL ANGIOLOGY. 2016;35(2):217-231
UEMS Training Requirements for Angiology and Vascular Medicine: European Standards of Postgraduate Medical Specialist Training (ETR Document)
Catalano M; Poredos P; Brodmann M; Wautrecht J-C; Carpentier P; Roztocil K; Nikol S; Dimakakos EP; Marakomichelakis G; Pecsvarady Z; Carlizza A; Sieron A; Stanek A; Olinic D; Stvrtinova V; Kozak M; Agewall S; Amann-Vesti B; Gallino A; Fitzgerald HP; Colgan M-P
Journal article: REVISTA ESPANOLA DE CARDIOLOGIA. 2016;69(2):177.e1-177.e62
Guía ESC/ERS 2015 sobre diagnóstico y tratamiento de la hipertensión pulmonar
Galiè N; Humbert M; Vachiery J-L; Gibbs S; Lang I; Torbicki A; Simonneau G; Peacock A; Noordegraaf AV; Beghetti M; Ghofrani A; Sánchez MÁG; Hansmann G; Klepetko W; Lancellotti P; Matucci M; McDonagh T; Pierard LA; Trindade PT; Zompatori M; Hoeper M; Aboyans V; Carneiro AV; Achenbach S; Agewall S; Allanore Y; Asteggiano R; Badano LP; Barberà JA; Bouvaist H; Bueno H; Byrne RA; Carerj S; Castro G; Erol Ç; Falk V; Funck-Brentano C; Gorenflo M; Grantonc J; Iung B; Kiely DG; Kirchhof P; Kjellstrom B; Landmesser U; Lekakis J; Lionis C; Lip GYH; Orfanos SE; Park MH; Piepoli MF; Ponikowski P; Revel M-P; Rigau D; Rosenkranz S; Völler H; Zamorano JL
Journal article: REVISTA ESPANOLA DE CARDIOLOGIA. 2016;69(2):176.e1-176.e77
Guía ESC 2015 sobre el tratamiento de pacientes con arritmiasventriculares y prevención de la muerte súbita cardiaca
de la muerte súbita cardiaca Avalada por: Associat GDTDLSE; Priori SG; Blomström-Lundqvist C; Mazzanti A; Blom N; Borggrefe M; Camm J; Elliott PM; Fitzsimons D; Hatala R; Hindricks G; Kirchhof P; Kjeldsen K; Kuck K-H; Hernández-Madrid A; Nikolaou N; Norekvål TM; Spaulding C; Van Veldhuisen DJ; Kolh P; Lip GYH; Agewall S; Barón-Esquivias G; Boriani G; Budts W; Bueno H; Capodanno D; Carerj S; Crespo-Leiro MG; Czerny M; Deaton C; Dobrev D; Erol Ç; Galderisi M; Gorenek B; Kriebel T; Lambiase P; Lancellotti P; Lane DA; Lang I; Manolis AJ; Morais J; Moreno J; Piepoli MF; Rutten FH; Sredniawa B; Zamorano JL; Zannad F
Article: EUROPEAN HEART JOURNAL. 2016;37(3):267-315
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)
Roffi M; Patrono C; Collet J-P; Mueller C; Valgimigli M; Andreotti F; Bax JJ; Borger MA; Brotons C; Chew DP; Gencer B; Hasenfuss G; Kjeldsen K; Lancellotti P; Landmesser U; Mehilli J; Mukherjee D; Storey RF; Windecker S; Baumgartner H; Gaemperli O; Achenbach S; Agewall S; Badimon L; Baigent C; Bueno H; Bugiardini R; Carerj S; Casselman F; Cuisset T; Erol C; Fitzsimons D; Halle M; Hamm C; Hildick-Smith D; Huber K; Iliodromitis E; James S; Lewis BS; Lip GYH; Piepoli MF; Richter D; Rosemann T; Sechtem U; Steg PG; Vrints C; Zamorano JL
Article: EUROPEAN HEART JOURNAL. 2016;37(1):67-119
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).
Galiè N; Humbert M; Vachiery J-L; Gibbs S; Lang I; Torbicki A; Simonneau G; Peacock A; Vonk Noordegraaf A; Beghetti M; Ghofrani A; Gomez Sanchez MA; Hansmann G; Klepetko W; Lancellotti P; Matucci M; McDonagh T; Pierard LA; Trindade PT; Zompatori M; Hoeper M; ESC Scientific Document Group
Journal article: REVISTA ESPANOLA DE CARDIOLOGIA. 2016;69(1):69.e1-69.e49
Guía ESC 2015 sobre el tratamiento de la endocarditis infecciosa
de la endocarditis infecciosa APLAEDC; Habib G; Lancellotti P; Antunes MJ; Bongiorni MG; Casalta J-P; del Zotti F; Dulgheru R; Khoury GE; Erba PA; Iung B; Miró JM; Mulder BJ; Plonska-Gosciniak E; Price S; Roos-Hesselink J; Snygg-Martin U; Thuny F; Mas PT; Vilacosta I; Zamorano JL; Erol Ç; Nihoyannopoulos P; Aboyans V; Agewall S; Athanassopoulos G; Aytekin S; Benzer W; Bueno H; Broekhuizen L; Carerj S; Cosyns B; de Backer J; de Bonis M; Dimopoulos K; Donal E; Drexel H; Flachskampf FA; Hall R; Halvorsen S; Hoen B; Kirchhof P; Lainscak M; Leite-Moreira AF; Lip GYH; Mestres CA; Piepoli MF; Punjabi PP; Rapezzi C; Rosenhek R; Siebens K; Tamargo J; Walker DM
Article: KARDIOLOGIA POLSKA. 2016;74(9):821-936
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli MF; Hoes AW; Agewall S; Albus C; Brotons C; Catapano AL; Cooney M-T; Corra U; Cosyns B; Deaton C; Graham I; Hall MS; Hobbs FDR; Lochen M-L; Lollgen H; Marques-Vidal P; Perk J; Prescott E; Redon J; Richter DJ; Smulders Y; Tiberi M; van der Worp HB; van Dis I; Verschuren WMM
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2016;23(2):194-205
Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration
Willeit P; Thompson SG; Agewall S; Bergstrom G; Bickel H; Catapano AL; Chien K-L; de Groot E; Empana J-P; Etgen T; Franco OH; Iglseder B; Johnsen SH; Kavousi M; Lind L; Liu J; Mathiesen EB; Norata GD; Olsen MH; Papagianni A; Poppert H; Price JF; Sacco RL; Yanez DN; Zhao D; Schminke U; Buelbuel A; Polak JF; Sitzer M; Hofman A; Grigore L; Doerr M; Su T-C; Ducimetiere P; Xie W; Ronkainen K; Kiechl S; Rundek T; Robertson C; Fagerberg B; Bokemark L; Steinmetz H; Ikram MA; Voelzke H; Lin H-J; Plichart M; Tuomainen T-P; Desvarieux M; McLachlan S; Schmidt C; Kauhanen J; Willeit J; Lorenz MW; Sander D
Journal article: REVISTA ESPANOLA DE CARDIOLOGIA. 2015;68(12):1126.e1-1126.e46
Artículo especial Guía ESC 2015 sobre el diagnóstico y tratamiento de las enfermedades del pericardio Grupo de Trabajo de la Sociedad Europea de Cardiología (ESC) para el diagnóstico y tratamiento de las enfermedades del pericardio
Surgery TEAFC-T; Adler Y; Charron P; Imazio M; Badano L; Barón-Esquivias G; Bogaert J; Brucato A; Gueret P; Klingel K; Lionis C; Maisch B; Mayosi B; Pavie A; Ristić AD; Tenas MS; Seferovic P; Swedberg K; Tomkowski W; Achenbach S; Agewall S; Al-Attar N; Ferrer JA; Arad M; Asteggiano R; Bueno H; Caforio ALP; Carerj S; Ceconi C; Evangelista A; Flachskampf F; Giannakoulas G; Gielen S; Habib G; Kolh P; Lambrinou E; Lancellotti P; Lazaros G; Linhart A; Meurin P; Nieman K; Piepoli MF; Price S; Roos-Hesselink J; Roubille F; Ruschitzka F; Sauleda JS; Sousa-Uvaa M; Voigt JU; Zamorano JL
Journal article: REVISTA ESPANOLA DE CARDIOLOGIA. 2015;68(12):1125.e1-1125.e64
Guía ESC 2015 sobre el tratamiento de los síndromes coronarios agudos en pacientes sin elevación persistente del segmento ST Grupo de Trabajo de la Sociedad Europea de Cardiología (ESC) para el tratamiento de los síndromes coronarios agudos en pacientes sin elevación persistente del segmento ST
Roffi M; Patrono C; Collet J-P; Mueller C; Valgimigli M; Andreotti F; Bax JJ; Borger MA; Brotons C; Chew DP; Gencer B; Hasenfuss G; Kjeldsen K; Lancellotti P; Landmesser U; Mehilli J; Mukherjee D; Storey RF; Windecker S; Baumgartner H; Gaemperli O; Achenbach S; Agewall S; Badimon L; Baigent C; Bueno H; Bugiardini R; Carerj S; Casselman F; Cuisset T; Erol Ç; Fitzsimons D; Halle M; Hamm C; Hildick-Smith D; Huber K; Iliodromitis E; James S; Lewis BS; Lip GYH; Piepoli MF; Richter D; Rosemann T; Sechtem U; Steg PG; Vrints C; Zamorano JL
Article: EUROPEAN HEART JOURNAL. 2015;36(44):3075-3128
2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).
Habib G; Lancellotti P; Antunes MJ; Bongiorni MG; Casalta J-P; Del Zotti F; Dulgheru R; El Khoury G; Erba PA; Iung B; Miro JM; Mulder BJ; Plonska-Gosciniak E; Price S; Roos-Hesselink J; Snygg-Martin U; Thuny F; Tornos Mas P; Vilacosta I; Zamorano JL; ESC Scientific Document Group
Article: EUROPEAN HEART JOURNAL. 2015;36(42):2921-2964
2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS).
Adler Y; Charron P; Imazio M; Badano L; Barón-Esquivias G; Bogaert J; Brucato A; Gueret P; Klingel K; Lionis C; Maisch B; Mayosi B; Pavie A; Ristic AD; Sabaté Tenas M; Seferovic P; Swedberg K; Tomkowski W; ESC Scientific Document Group
Article: EUROPACE. 2015;17(11):1601-1687
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).
Priori SG; Blomström-Lundqvist C; Mazzanti A; Blom N; Borggrefe M; Camm J; Elliott PM; Fitzsimons D; Hatala R; Hindricks G; Kirchhof P; Kjeldsen K; Kuck K-H; Hernandez-Madrid A; Nikolaou N; Norekvål TM; Spaulding C; Van Veldhuisen DJ; Task Force for the Management of Patients with Ven
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2015;17(11):1144-1151
Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database Initiative
von Lueder TG; Girerd N; Atar D; Agewall S; Lamiral Z; Kanbay M; Pitt B; Dickstein K; Zannad F; Rossignol P
Article: EUROPEAN HEART JOURNAL. 2015;36(41):2793-2867
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)
Priori SG; Blomstrom-Lundqvist C; Mazzanti A; Blom N; Borggrefe M; Camm J; Elliott PM; Fitzsimons D; Hatala R; Hindricks G; Kirchhof P; Kjeldsen K; Kuck K-H; Hernandez-Madrid A; Nikolaou N; Norekval TM; Spaulding C; Van Veldhuisen DJ; Kolh P; Lip GYH; Agewall S; Baron-Esquivias G; Boriani G; Budts W; Bueno H; Capodanno D; Carerj S; Crespo-Leiro MG; Czerny M; Deaton C; Dobrev D; Erol C; Galderisi M; Gorenek B; Kriebel T; Lambiase P; Lancellotti P; Lane DA; Lang I; Manolis AJ; Morais J; Moreno J; Piepoli MF; Rutten FH; Sredniawa B; Zamorano JL; Zannad F
Article: EUROPEAN HEART JOURNAL. 2015;36(40):2677-2680
Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC
Rosano GMC; Lewis B; Agewall S; Wassmann S; Vitale C; Schmidt H; Drexel H; Patak A; Torp-Pedersen C; Kjeldsen KP; Tamargo J
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2015;116(6):838-844
Risk Factors and Markers for Acute Myocardial Infarction With Angiographically Normal Coronary Arteries
Daniel M; Ekenback C; Agewall S; Brolin EB; Caidahl K; Cederlund K; Collste O; Eurenius L; Frick M; Younis-Hassan S; Henareh L; Jemberg T; Malmqvist K; Spaak J; Sorensson P; Hofman-Bang C; Tornvall P
Article: CIRCULATION-HEART FAILURE. 2015;8(5):887-896
Carvedilol Compared With Metoprolol Succinate in the Treatment and Prognosis of Patients With Stable Chronic Heart Failure Carvedilol or Metoprolol Evaluation Study
Froehlich H; Zhao J; Taeger T; Cebola R; Schellberg D; Katus HA; Grundtvig M; Hole T; Atar D; Agewall S; Frankenstein L
Article: BMC CARDIOVASCULAR DISORDERS. 2015;15:63
Neither endothelial function nor carotid artery intima-media thickness predicts coronary computed tomography angiography plaque burden in clinically healthy subjects: a cross-sectional study
Brolin EB; Agewall S; Brismar TB; Caidahl K; Tornvall P; Cederlund K
Article: ATHEROSCLEROSIS. 2015;241(1):87-91
Myocarditis or "true" infarction by cardiac magnetic resonance in patients with a clinical diagnosis of myocardial infarction without obstructive coronary disease: A meta-analysis of individual patient data
Tornvall P; Gerbaud E; Behaghel A; Chopard R; Collste O; Laraudogoitia E; Leurent G; Meneveau N; Montaudon M; Perez-David E; Soerensson P; Agewall S
Journal article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(Suppl 2):1011-1012
AB0355 Anti-Rheumatic Therapy Reduces Syndecan-1 Shedding in Rheumatoid Arthritis (RA)
Hollan I; Vuong TT; Reine TM; Hjeltnes G; Lyberg T; Agewall S; Wiik A; Mikkelsen K; Førre ØT; Kolset SO
Article: CLINICA CHIMICA ACTA. 2015;443:78-84
Troponins in heart failure
Omland T; Rosjo H; Giannitsis E; Agewall S
Article: AMERICAN HEART JOURNAL. 2015;169(2):257-265.e1
Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
Hall TS; Hallen J; Krucoff MW; Roe MT; Brennan DM; Agewall S; Atar D; Lincoff AM
Article: CARDIOLOGY. 2015;131(4):209-217
The Effects of Climate Change on Cardiac Health
De Blois J; Kjellstrom T; Agewall S; Ezekowitz JA; Armstrong PW; Atar D
Article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2015;1(1):31-36
ESC guidelines adherence is associated with improved survival in patients from the Norwegian Heart Failure Registry
De Blois J; Fagerland MW; Grundtvig M; Semb AG; Gullestad L; Westheim A; Hole T; Atar D; Agewall S
Article: EUROPEAN HEART JOURNAL. 2014;35(43):3033-3069k
2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.
Konstantinides SV; Torbicki A; Agnelli G; Danchin N; Fitzmaurice D; Galiè N; Gibbs JSR; Huisman MV; Humbert M; Kucher N; Lang I; Lankeit M; Lekakis J; Maack C; Mayer E; Meneveau N; Perrier A; Pruszczyk P; Rasmussen LH; Schindler TH; Svitil P; Vonk Noordegraaf A; Zamorano JL; Zompatori M; Task Force for the Diagnosis and Management of Acu
Article: ANGIOLOGY. 2014;65(10):932-936
Relationship Between Oxidized LDL, IgM, and IgG Autoantibodies to ox-LDL Levels With Recurrent Cardiovascular Events in Swedish Patients With Previous Myocardial Infarction
Crisby M; Henareh L; Agewall S
Article: EUROPEAN JOURNAL OF ANAESTHESIOLOGY. 2014;31(10):517-573
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).
Kristensen SD; Knuuti J; Saraste A; Anker S; Bøtker HE; De Hert S; Ford I; Gonzalez Juanatey JR; Gorenek B; Heyndrickx GR; Hoeft A; Huber K; Iung B; Kjeldsen KP; Longrois D; Luescher TF; Pierard L; Pocock S; Price S; Roffi M; Sirnes PA; Uva MS; Voudris V; Funck-Brentano C; Authors/Task Force Members
Article: EUROPEAN HEART JOURNAL. 2014;35(35):2383-2431
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).
Kristensen SD; Knuuti J; Saraste A; Anker S; Bøtker HE; Hert SD; Ford I; Gonzalez-Juanatey JR; Gorenek B; Heyndrickx GR; Hoeft A; Huber K; Iung B; Kjeldsen KP; Longrois D; Lüscher TF; Pierard L; Pocock S; Price S; Roffi M; Sirnes PA; Sousa-Uva M; Voudris V; Funck-Brentano C; Authors/Task Force Members
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2014;34(5):389-396
The early diastolic myocardial velocity: a marker of increased risk in patients with coronary heart disease
Johnson J; Manouras A; Bergholm F; Brodin LA; Agewall S; Henareh L
Article: SLEEP MEDICINE. 2014;15(7):762-768
Myeloid-related protein-8/14 and C-reactive protein in individuals evaluated for obstructive sleep apnea
Hall TS; Herrscher TE; Jarolim P; Fagerland MW; Jensen T; Agewall S; Atar D; Hallen J
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2014;34(4):322-326
Conventional treatment after myocardial infarction in routine clinical practice results in regression of left common carotid intima-media thickness
Jogestrand T; Agewall S; Gustafsson T; Henareh L
Article: SLEEP AND BREATHING. 2014;18(2):351-358
Obstructive sleep apnea: no independent association to troponins
Hall TS; Herrscher T; Jarolim P; Fagerland MW; Jensen T; Hallen J; Agewall S; Atar D
Article: ANGIOLOGY. 2014;65(5):443-449
Subclinical Atherosclerosis, Endothelial Function, and Serum Inflammatory Markers in Chronic Kidney Disease Stages 3 to 4
Ghanavatian S; Diep LM; Barany P; Heimburger O; Seeberger A; Stenvinkel P; Rohani M; Agewall S
Article: LAKARTIDNINGEN. 2014;111(15):680-681
[New guidelines for diagnosis and management of stable angina pectoris. Recommendations from the European Society of Cardiology].
Agewall S
Article: TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING. 2014;134(5):510
[New guidelines for angina pectoris].
Agewall S
Article: CURRENT ATHEROSCLEROSIS REPORTS. 2014;16(3):396
"Troponin Elevation in Coronary Ischemia and Necrosis"
Agewall S; Giannitsis E
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2013;69(10):1747-1755
Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction: a propensity score-matched cohort study
Frankenstein L; Katus HA; Grundtvig M; Hole T; de Blois J; Schellberg D; Atar D; Zugck C; Agewall S
Journal article: EUROPEAN HEART JOURNAL. 2013;34(suppl_1):p5446
Presence of eNOS TT genotype is associated with a poor prognosis in patients with a previous myocardial infarction
Agewall S; Henareh L; Norman B
Article: EUROPEAN HEART JOURNAL. 2013;34(23):1708-1713b
Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy
Agewall S; Cattaneo M; Collet JP; Andreotti F; Lip GYH; Verheugt FWA; Huber K; Grove EL; Morais J; Husted S; Wassmann S; Rosano G; Atar D; Pathak A; Kjeldsen K; Storey RF
Article: EUROPEAN HEART JOURNAL. 2013;34(22):1621-1629
Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy
Verheugt FWA; Clemmensen P; Mehran R; Agewall S; Pocock SJ; Goldstein S; Torp-Pedersen C; Simoons ML; Borer JS; Khder YM; Burton P; Deliargyris E; McMurray JJV; Berkowitz SD; Stough WG; Zannad F
Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2013;31(3):415-421
Serum levels of lipoprotein(a) and E-selectin are reduced in rheumatoid arthritis patients treated with methotrexate or methotrexate in combination with TNF-α-inhibitor
Hjeltnes G; Hollan I; Forre O; Wiik A; Lyberg T; Mikkelsen K; Agewall S
Article: TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING. 2013;133(7):739
[New European guidelines for heart failure].
Agewall S
Article: LAKARTIDNINGEN. 2013;110(13-14):672-673
[New European guidelines for acute and chronic heart failure].
Agewall S
Article: LAKARTIDNINGEN. 2013;110(13-14):664
[Wanted: Politics against heart attacks].
Agewall S; Rydén L; Perk J; Rosengren A; Boman K; Hellénius M-L; Ros I
Article: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2013;61(3):250-257
Esomeprazole for Prevention and Resolution of Upper Gastrointestinal Symptoms in Patients Treated With Low-dose Acetylsalicylic Acid for Cardiovascular Protection: The OBERON Trial
Scheiman JM; Herlitz J; van Zanten SJV; Lanas A; Agewall S; Naucler EC; Svedberg L-E; Nagy P
Article: JOURNAL OF INTERNAL MEDICINE. 2013;273(2):189-196
Myocardial infarction with normal coronary arteries is common and associated with normal findings on cardiovascular magnetic resonance imaging: results from the Stockholm Myocardial Infarction with Normal Coronaries study
Collste O; Sorensson P; Frick M; Agewall S; Daniel M; Henareh L; Ekenback C; Eurenius L; Guiron C; Jernberg T; Hofman-Bang C; Malmqvist K; Nagy E; Arheden H; Tornvall P
Journal article: REVISTA PORTUGUESA DE CARDIOLOGIA. 2013;32(1):81-82
ESC/EAS Guidelines for the Management of Dyslipidaemias
Reiner Ž; Catapano AL; De Backer G; Graham I; Taskinen M-R; Wiklund O; Agewall S; Alegria E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Filardi PP; Riccardi G; Storey RF; Wood. D
Journal article: REVISTA PORTUGUESA DE CARDIOLOGIA. 2013;32(1):83-84
ESC/EAS Guidelines for the Management of Dyslipidaemias
Reiner Ž; Catapano AL; De Backer G; Graham I; Taskinen M-R; Wiklund O; Agewall S; Alegria E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Filardi PP; Riccardi G; Storey RF; Wood. D
Article: HEART. 2013;99(1):30-34
Impaired endothelial function in persons with obstructive sleep apnoea: impact of obesity
Namtvedt SK; Hisdal J; Randby A; Agewall S; Stranden E; Somers VK; Rosjo H; Omland T
Article: ANGIOLOGY. 2012;63(7):500-503
Risk Factors for Myocardial Infarction With Normal Coronary Arteries and Myocarditis Compared With Myocardial Infarction With Coronary Artery Stenosis
Agewall S; Daniel M; Eurenius L; Ekenback C; Skeppholm M; Malmqvist K; Hofman-Bang C; Collste O; Frick M; Henareh L; Jernberg T; Tornvall P
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2012;32(5):400-403
Echogenicity of the carotid intima-media complex and cardiovascular risk factors
De Blois J; Stranden E; Jogestrand T; Henareh L; Agewall S
Article: CARDIOVASCULAR DIABETOLOGY. 2012;11:93
2-h postchallenge plasma glucose predicts cardiovascular events in patients with myocardial infarction without known diabetes mellitus
Henareh L; Agewall S
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2012;367(4):319-328
Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
Gerstein HC; Bosch J; Dagenais GR; Diaz R; Jung H; Maggioni AP; Pogue J; Probstfield J; Ramachandran A; Riddle MC; Ryden LE; Yusuf S
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2012;367(4):309-318
n-3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
Bosch J; Gerstein HC; Dagenais GR; Diaz R; Dyal L; Jung H; Maggiono AP; Probstfield J; Ramachandran A; Riddle MC; Ryden LE; Yusuf S
Article: JOURNAL OF RHEUMATOLOGY. 2012;39(7):1341-1347
Relations of Serum COMP to Cardiovascular Risk Factors and Endothelial Function in Patients with Rheumatoid Arthritis Treated with Methotrexate and TNF-α Inhibitors
Hjeltnes G; Hollan I; Forre O; Wiik A; Lyberg T; Mikkelsen K; Agewall S
Article: LANCET. 2012;379(9831):2053-2062
Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data.
Lorenz MW; Polak JF; Kavousi M; Mathiesen EB; Völzke H; Tuomainen T-P; Sander D; Plichart M; Catapano AL; Robertson CM; Kiechl S; Rundek T; Desvarieux M; Lind L; Schmid C; DasMahapatra P; Gao L; Ziegelbauer K; Bots ML; Thompson SG; PROG-IMT Study Group
Article: CLINICA CHIMICA ACTA. 2012;413(9-10):933-937
Prognostic value of combining high sensitive troponin T and N-terminal pro B-type natriuretic peptide in chest pain patients with no persistent ST-elevation
Melki D; Lind S; Agewall S; Jernberg T
Article: GIORNALE ITALIANO DI CARDIOLOGIA. 2012;13(3):171-228
ESC guidelines for the treatment of acute coronary syndromes in patients without persistent ST segment elevation at presentation. Task Force for the Treatment of Acute Coronary Syndromes (SCA) in Patients without Persistent Leveling of the ST Tract at the Presentation of the European Society of Cardiology (ESC)
Hamm CW; Bassand J-P; Agewall S; Bax J; Boersma E; Bueno H; Caso P; Dudek D; Gielen S; Huber K; Ohman M; Petrie MC; Sonntag F; Uva MS; Storey RF; Wijns W; Zahger D; Bax JJ; Auricchio A; Baumgartner H; Ceconi C; Dean V; Deaton C; Fagard R; Funck-Brentano C; Hasdai D; Hoes A; Knuuti J; Kolh P; McDonagh T; Moulin C; Poldermans D; Popescu BA; Reiner Z; Sechtem U; Sirnes PA; Torbicki A; Vahanian A; Windecker S; Windecker S; Achenbach S; Badimon L; Bertrand M; Botker HE; Collet J-P; Crea F; Danchin N; Falk E; Goudevenos J; Gulba D; Hambrecht R; Herrmann J; Kastrati A; Kjeldsen K; Kristensen SD; Lancellotti P; Mehilli J; Merkely B; Montalescot G; Neumann F-J; Neyses L; Perk J; Roffi M; Romeo F; Ruda M; Swahn E; Valgimigli M; Vrints CJM; Widimsky P
Article: TURK KARDIYOLOJI DERNEGI ARSIVI. 2012;40 Suppl 1:5-60
[ESC guidelines for the treatment and diagnosis of peripheral artery disease. Guideline includes extracranial carotid artery, vertebral, mesenteric, renal, upper and lower extremity arteries].
Tendera M; Aboyans V; Bartelink L; Baumgartner I; Clement D; Collet J-P; Cremonesi A; De Carlo M; Erbel R; Fowkes FGR; Heras M; Kownator S; Minar E; Ostergren J; Poldermans D; Riambau V; Roffi M; Rother J; Sievert H; van Sambeek M; Zeller T; Avrupa Kardiyoloji Derneği ESC Periferik Atardamar; Avrupa Inme Organizasyonu (ESO) tarafindan destekl
Journal article: REVISTA ESPANOLA DE CARDIOLOGIA. 2012;65(2):173.e1-173.e55
Guía de práctica clínica de la ESC para el manejo del síndrome coronario agudo en pacientes sin elevación persistente del segmento ST
la Sociedad Europea de Cardiología GDTPEMD; Hamm CW; Bassand J-P; Agewall S; Bax J; Boersma E; Bueno H; Caso P; Dudek D; Gielen S; Huber K; Ohman M; Petrie MC; Sonntag F; Uva MS; Storey RF; Wijns W; Zahger D
Journal article: REVISTA ESPANOLA DE CARDIOLOGIA. 2012;65(2):173
ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation
Hamm CW; Bassand J-P; Agewall S; Bax J; Boersma E; Bueno H; Caso P; Dudek D; Gielen S; Huber K; Ohman M; Petrie MC; Sonntag F; Uva MS; Storey RF; Wijns W; Zahger D
Article: LAKARTIDNINGEN. 2012;109(1-2):18
[Troponin can be increased in healthy persons following moderate exercise].
Agewall S
Article: ANGIOLOGY. 2012;63(1):17-23
Some Aspects of Preventing Coronary Heart Disease
Agewall S
Article: CLINICAL LABORATORY. 2012;58(9-10):1029-1036
Changes in Diagnosing Non-ST-Segment Elevation Myocardial Infarction after the Introduction of a New High-Sensitivity Cardiac Troponin T Assay: A Single-Centre Experience
Hall TS; Hallen J; Agewall S; Atar D; Jensen T
Article: LAKARTIDNINGEN. 2011;108(50):2644-2645
[New European guidelines for myocardial infarction without ST-segment elevation. Quicker diagnosis saves money--demands for angiography also during weekends costs more].
Agewall S
Article: EUROPEAN HEART JOURNAL. 2011;39(23):2999-3054
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Hamm CW; Bassand J-P; Agewall S; Bax J; Boersma E; Bueno H; Caso P; Dudek D; Gielen S; Huber K; Ohman M; Petrie MC; Sonntag F; Uva MS; Storey RF; Wijns W; Zahger D
Article: REVISTA PORTUGUESA DE CARDIOLOGIA. 2011;30(12):951-1005
Myocardial revascularization
Wijns W; Kolh P; Danchin N; Di Mario C; Falk V; Folliguet T; Garg S; Huber K; James S; Knuuti J; Lopez-Sendon J; Marco J; Menicanti L; Ostojic M; Piepoli MF; Pirlet C; Pomar JL; Reifart N; Ribichini FL; Schalij MJ; Sergeant P; Serruys PW; Silber S; Uva MS; Taggart D; Vahanian A; Auricchio A; Bax J; Ceconi C; Dean V; Filippatos G; Funck-Brentano C; Hobbs R; Kearney P; McDonagh T; Popescu BA; Reiner Z; Sechtem U; Sirnes PA; Tendera M; Vardas PE; Widimsky P; Kolh P; Alfieri O; Dunning J; Elia S; Kappetein P; Lockowandt U; Sarris G; Vouhe P; Kearney P; von Segesser L; Agewall S; Aladashvili A; Alexopoulos D; Antunes MJ; Atalar E; de la Riviere AB; Doganov A; Eha J; Fajadet J; Ferreira R; Garot J; Halcox J; Hasin Y; Janssens S; Kervinen K; Laufer G; Legrand V; Nashef SAM; Neumann F-J; Niemela K; Nihoyannopoulos P; Noc M; Piek JJ; Pirk J; Rozenman Y; Sabate M; Starc R; Thielmann M; Wheatley DJ; Windecker S; Zembala M
Journal article: REVISTA ESPANOLA DE CARDIOLOGIA. 2011;64(12):1168
ESC/EAS Guidelines for the management of dyslipidaemias
de Cardiología y de la Sociedad Europea de Aterosc GDTDLSE; Reiner Ž; Catapano AL; De Backer G; Graham I; Taskinen M-R; Wiklund O; Agewall S; Alegría E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Filardi PP; Riccardi G; Storey RF; Wood D
Article: TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING. 2011;131(23):2340
[New European guidelines for acute myocardial infarction].
Agewall S; Atar D
Article: TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING. 2011;131(22):2226
Physical exertion may cause high troponin levels.
Agewall S; Tjora S
Article: EUROPEAN HEART JOURNAL. 2011;40(22):2851-2906
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases
Tendera M; Aboyans V; Bartelink M-L; Baumgartner I; Clement D; Collet J-P; Cremonesi A; De Carlo M; Erbel R; Fowkes FGR; Heras M; Kownator S; Minar E; Ostergren J; Poldermans D; Riambau V; Roffi M; Rother J; Sievert H; van Sambeek M; Zeller T; Bax J; Auricchio A; Baumgartner H; Ceconi C; Dean V; Deaton C; Fagard R; Funck-Brentano C; Hasdai D; Hoes A; Knuuti J; Kolh P; McDonagh T; Moulin C; Poldermans D; Popescu B; Reiner Z; Sechtem U; Sirnes PA; Torbicki A; Vahanian A; Windecker S; Kolh P; Torbicki A; Agewall S; Blinc A; Bulvas M; Cosentino F; De Backer T; Gottsater A; Gulba D; Guzik TJ; Jonsson B; Kesmarky G; Kitsiou A; Kuczmik W; Larsen ML; Madaric J; Mas J-L; McMurray JJV; Micari A; Mosseri M; Muller C; Naylor R; Norrving B; Oto O; Pasierski T; Plouin P-F; Ribichini F; Ricco J-B; Ruilope L; Schmid J-P; Schwehr U; Sol BGM; Sprynger M; Tiefenbacher C; Tsioufis C; Van Damme H
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2011;40(6):422-427
Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients
Hjeltnes G; Hollan I; Forre O; Wiik A; Mikkelsen K; Agewall S
Article: SCANDINAVIAN CARDIOVASCULAR JOURNAL. 2011;45(4):198-204
Diagnostic value of high sensitive troponin T in chest pain patients with no persistent ST-elevations
Melki D; Lind S; Agewall S; Jernberg T
Article: EUROPEAN HEART JOURNAL. 2011;39(14):1769-1818
ESC/EAS GUIDELINES ESC/EAS Guidelines for the management of dyslipidaemias
Reiner Z; Catapano AL; De Backer G; Graham I; Taskinen M-R; Wiklund O; Agewall S; Alegria E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Filardi PP; Riccardi G; Storey RF; Wood D
Article: ANNALS OF THE RHEUMATIC DISEASES. 2011;70(5):812-817
Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study
Provan SA; Semb AG; Hisdal J; Stranden E; Agewall S; Dagfinrud H; Angel K; Atar D; Kvien TK
Article: JOURNAL OF RHEUMATOLOGY. 2011;38(4):606-612
Early Prediction of Increased Arterial Stiffness in Patients with Chronic Inflammation: A 15-year Followup Study of 108 Patients with Rheumatoid Arthritis
Provan SA; Angel K; Semb AG; Mowinckel P; Agewall S; Atar D; Kvien TK
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2011;45(2):151-158
Incremental value of a combination of cardiac troponin T, N-terminal pro-brain natriuretic peptide and C-reactive protein for prediction of mortality in end-stage renal disease
Hallen J; Madsen L; Ladefoged S; Fagerland MW; Serebruany VL; Agewall S; Atar D
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2011;146(3):354-358
Gender differences among Norwegian patients with heart failure
Brandsaeter B; Atar D; Agewall S
Article: CLINICAL LABORATORY. 2011;57(7-8):615-618
Amyotrophic Lateral Sclerosis (ALS), A Novel Rare Cause of Elevated Plasma Troponin T Levels
von Lueder TG; Melsom MN; Atar D; Agewall S
Article: CLINICAL LABORATORY. 2011;57(9-10):771-776
The Course of D-dimer, High-Sensitivity C-reactive Protein and Pro-B-Type Natriuretic Peptide in Patients with Non-ST-Elevation Myocardial Infarction
Ghanavatian S; Stein RA; Atar D; Hole L; Agewall S
Article: EUROPEAN HEART JOURNAL. 2010;31(20):2501-2555
Guidelines on myocardial revascularization.
Task Force on Myocardial Revascularization of the ; European Association for Percutaneous Cardiovascul; Wijns W; Kolh P; Danchin N; Di Mario C; Falk V; Folliguet T; Garg S; Huber K; James S; Knuuti J; Lopez-Sendon J; Marco J; Menicanti L; Ostojic M; Piepoli MF; Pirlet C; Pomar JL; Reifart N; Ribichini FL; Schalij MJ; Sergeant P; Serruys PW; Silber S; Sousa Uva M; Taggart D
Article: ATHEROSCLEROSIS. 2010;212(2):586-588
Patients' self-estimated likelihood of taking a statin as prescribed after different types of prognostic information
Roshan F; Saeed M; Agewall S
Article: LANCET. 2010;376(9744):875-885
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Swedberg K; Komajda M; Boehm M; Borer JS; Ford I; Dubost-Brama A; Lerebours G; Tavazzi L
Article: EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. 2010;38 Suppl:S1-S52
Guidelines on myocardial revascularization.
Task Force on Myocardial Revascularization of the ; European Association for Percutaneous Cardiovascul; Kolh P; Wijns W; Danchin N; Di Mario C; Falk V; Folliguet T; Garg S; Huber K; James S; Knuuti J; Lopez-Sendon J; Marco J; Menicanti L; Ostojic M; Piepoli MF; Pirlet C; Pomar JL; Reifart N; Ribichini FL; Schalij MJ; Sergeant P; Serruys PW; Silber S; Sousa Uva M; Taggart D
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2010;30(5):354-359
Impact of physical activity and body composition on heart function and morphology in middle-aged, abdominally obese women
Eriksson M; Udden J; Hemmingsson E; Agewall S
Article: ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES. 2010;27(6):651-658
Intima-Media Thickness of Common Carotid and Brachial Arteries and Prothrombin Fragment 1+2 Are Associated with Left Ventricular Diastolic Dysfunction in Patients with Myocardial Infarction
Henareh L; Jedefors C; Jogestrand T; Brodin LA; Agewall S
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2010;105(9):1229-1234
Effect of Angiotensin-Converting Enzyme Inhibition on One-Year Mortality and Frequency of Repeat Acute Myocardial Infarction in Patients With Acute Myocardial Infarction
Milonas C; Jernberg T; Lindback J; Agewall S; Wallentin L; Stenestrand U
Journal article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2010;55(10):a118.e1107
HIGH SENSITIVE TROPONIN T RULES OUT MYOCARDIAL INFARCTION 2 HOURS FROM ADMISSION IN CHEST PAIN PATIENTS.
Melki D; Lind S; Agewall S; Jernberg T
Article: JOURNAL OF CARDIAC FAILURE. 2010;16(3):225-229
COPD Predicts Mortality in HF: The Norwegian Heart Failure Registry
De Blois J; Simard S; Atar D; Agewall S
Journal article: TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING. 2010;130(5):466
Överbehandling av patienter med demens
Agewall S
Article: THROMBOSIS RESEARCH. 2009;124(5):526-530
Prothrombin fragment 1+2 is associated with intima media thickness of the carotid artery in patients with myocardial infarction
Henareh L; Jogestrand T; Agewall S
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2009;29(5):372-375
Evaluation of endothelial function using finger plethysmography
Faizi AK; Kornmo DW; Agewall S
Article: HEART AND VESSELS. 2009;24(4):260-266
Expression of heat shock proteins and nitrotyrosine in small arteries from patients with coronary heart disease
Paier A; Agewall S; Kublickiene K
Article: HEART AND VESSELS. 2009;24(2):90-95
Circulating levels of autoantibodies to oxidized low-density lipoprotein and C-reactive protein levels correlate with endothelial function in resistance arteries in men with coronary heart disease
Crisby M; Kublickiene K; Henareh L; Agewall S
Journal article: ARTERY RESEARCH. 2008;2(3):107
P2.03 Early Inflammation Can Predict Arterial Stiffness: A 15-Year Longitudinal Study of 102 Patients with Rheumatoid Arthtritis
Provan SA; Angel K; Semb AG; Mowinckel P; Agewall S; Atar D; Kvien TK
Journal article: ARTERY RESEARCH. 2008;2(3):107-108
P2.06 Levels of NT-proBNP are Associated with Arterial Stiffness in Patients with Rheumatoid Arthritis
Provan SA; Angel K; Mowinckel P; Agewall S; Atar D; Kvien TK
Article: CORONARY ARTERY DISEASE. 2008;19(5):289-292
Quality of life and insulin resistance in patients with coronary heart disease
Agewall S; Henareh L
Article: LAKARTIDNINGEN. 2008;105(16):1192-1193
[Five different types of myocardial infarction defined by new guidelines].
Agewall S
Article: ATHEROSCLEROSIS. 2008;196(1):49-58
Acute dilatation to phytoestrogens and estrogen receptor subtypes expression in small arteries from women with coronary heart disease
Cruz MN; Agewall S; Schenck-Gustafsson K; Kublickiene K
Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2007;49(23):2249-2255
The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial
Fox KAA; Antman EM; Montalescot G; Agewall S; SomaRaju B; Verheugt FWA; Lopez-Sendon J; Hod H; Murphy SA; Braunwald E
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2007;99(10):1357-1359
Usefulness of troponin levels below the diagnostic cut-off level for acute myocardial infarction in predicting prognosis in unselected patients admitted to the coronary care unit
Agewall S; Olsson T; Lowbeer C
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2007;27(1):60-66
Disturbed glucose metabolism is associated with left ventricular dysfunction using tissue Doppler imaging in patients with myocardial infarction
Henareh L; Lind B; Brodin L-A; Agewall S
Article: CLINICAL SCIENCE. 2006;111(1):87-91
Atorvastatin normalizes endothelial function in healthy smokers
Agewall S; Hernberg A
Article: AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY. 2006;290(5):H1969-H1975
Acute responses to phytoestrogens in small arteries from men with coronary heart disease
Cruz MN; Luksha L; Logman H; Poston L; Agewall S; Kublickiene K
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2006;354(14):1464-1476
Comparison of fondaparinux and enoxaparin in acute coronary syndromes
Yusuf S; Mehta SR; Bassand JP; Budaj A; Chrolavicius S; Fox KAA; Granger CB; Joyner C; Peters RJG; Wallentin L; Avezum A; Boden W; Cardona E; Ceremuzynski L; Col J; Commerford PJ; Diaz R; Faxon D; Flather M; Fodor G; Franzosi MG; Granger C; Halon D; Hunt D; Karatzas N; Keltai M; Kenda M; Kim JH; Lanas F; Lau CP; Lewis BS; Morais J; Moccetti T; Pais P; Paolasso E; Parkhomenko A; Petrauskiene B; Piegas L; Pipilis A; Robaayah D; Ruda M; Rumboldt Z; Rupprecht HJ; Sitkei E; Steg PG; Swahn E; Theroux P; Valentin V; Varigos J; Weitz J; White H; Widimsky P; Xavier D; Zhu JR; Ameriso S; Bonilla C; Braekken S; Chan YK; Chen W; Chenniappan M; Cohen E; Cottin Y; Csiba L; Czepiel A; De Raedt H; Finet G; Gardinale E; Gaxiola E; Gorecki A; Gregor P; Happola O; Heras M; Himbert D; Irkin O; Isaaz K; Iyengar SS; Kalvach P; Kevers L; Klosiewicz-Wasek B; Laine M; Leys D; Lundstrom E; Lusic I; Lutay Y; Maggioni A; Massaro A; Mayosi BM; Moulin T; Narendra J; Naslund U; Peeters A; Penicka M; Perakis A; Petersen P; Polic S; Radhakrishnan S; Renkin J; Stockins B; Sundararajan R; Thygesen K; Turazza F; Van Belle E; Vik-Mo H; Zaborski J; Sleight P; Anderson JL; Johnstone DE; Hirsh J; deMets D; Holmes DR; Meeks B; Afzal R; Pogue J; Boccalon S; Chrysler K; Cracknell B; Horsman C; Hoskin T; Jedrzejowski B; Johnson J; Kotlan S; Lawrence M; Smiley M; Stevens C; Yallup R; Connolly S; Demers C; Devereaux PJ; Healey J; Lonn E; Magloire P; McKelvie R; Morillo C; Natarajan M; Rokoss M; Teo K; Valettas N; Velianou J; Albisu JP; Amuchastegui M; Bello FA; Bluguermann JJ; Bono JO; Caccavo A; Carlevaro OO; Cassettari A; Cuneo C; Farrás HA; Fuselli J; Garrido M; Guerrero R; Hasbani E; Hominal MA; Hrabar A; Marquez LL; Luciardi HL; Riera LM; Marzetti EM; Memoli R; Nordaby R; Orlandini AD; Perez M; Piasentin JA; Ramos HR; Risolo AM; Sala J; Salomone O; Schygiel PO; Ubaldini J; Vico M; Amerena J; Arnolda L; Aroney G; Boyd P; Cahill P; Chew D; Counsell JT; Cross D; Edington J; Fitzpatrick D; Hicks P; Horowitz JD; Horrigan MCG; New G; Owensby D; Schoeman M; Thompson P; Tulloch G; Waites J; Whelan A; Ziffer R; Huber K; Jordanova N; Al Shawafi K; Convens C; Coussement P; de Meester A; El Allaf D; Janssens L; Marcovitch O; Muyldermans L; Roosen J; Soeur F; Van Lierde J; Vrolix M; Leaes P; Carvalho AC; Schramm EC; Mora RD; Amino JD; Dutra O; Manenti ERF; Gun C; Saraiva JFK; Hayashi EK; Lichter A; Lima A; Marin-Neto JA; Teixeira SPM; Abrantes JAM; Baracioli LM; Nicolau JC; Maia LN; Jaeger CP; Esteves JP; Rabelo A; Ramos RF; Reis G; Rossi P; dos Santos FR; Teixeira MS; Silveira DS; Lemos MABT; Timerman A; Greque GV; Vaz R; Bhargava R; Brons S; Colclough M; Constance C; Costi P; Dacyk A; Davies T; Diodati J; Dupuis R; Elliott H; Fell DA; Fung AY; Gladstone PJS; Gosselin G; Grondin F; Huynh T; Janzen I; Kalaparambath T; Kornder J; Kouz S; Kuritzky R; Labelle-Stimac S; Lamothe M; Lauzon C; LeMay M; Ma P; MacCallum GC; McCallum A; Mitchell D; Montigny M; Nguyen N; Pearce M; Pistawka KJ; Rebane T; Roy M; Senaratne M; Smith J; Stimac J; Traboulsi M; Vizel S; Weeks A; Zadra R; Zimmerman RH; Alcaino ME; Castro P; Chen J; Chen J; Chen JL; Fan W; Ge J; Hu D; Huang J; Jingxuan G; Ke Y; Ma H; Wu Y; Yingxian S; Yu B; Zhu W; Bakula M; Bergovec M; Lukin A; Milicevic G; Padovan M; Polic S; Raguz M; Aschermann M; Belohlavek J; Bocek P; Branny M; Budesinsky T; Groch L; Holm F; Jansky P; Jelínek P; Jirka V; Kaislerová M; Konecny P; Lisa L; Maly M; Marcinek G; Oscipovsky M; Stumar J; Vácha M; Nielsen T; Vigholt E; Laanmets P; Soopold U; Voitk J; Näveri H; Niemela M; Peuhkurinen K; Tuomainen P; Ylitalo A; Py A; Amat G; Bessede G; Boschat J; Carrie D; Charbonnier B; Coliet JP; Dambrine P; Dubois-Rande JL; Ferrari E; Fouche R; Grollier G; Jaboureck O; Ketelers R; Khalife K; Leroy F; Lognone T; Macquin-Mavier I; Montalescot G; Pacouret G; Poulard JE; Puel J; Richard M; Schiele F; Bischoff KO; Buerke M; Buerke U; Dominick K; Drexler H; Feiler A; Guelker H; Haltern G; Katus HA; Klauss V; Klutmann M; Koeth O; Meinhardt G; Muenzel TM; Nitschke T; Offterdinger M; Rieber J; Schieffer B; Stangl K; Stangl V; vom Dahl J; Witzenbichler B; Zeymer U; Alexopoulos D; Blassopoulou N; Christon A; Fotiadis I; Foussas S; Grapsas N; Moschos N; Papasteriadis E; Symeonidis D; Tyrologos A; Leung WS; Li SK; Arabadzisz H; Csikazs J; Dancs T; Davidovits Z; Edes I; Farkas E; Herczeg B; Janos S; Janosi A; Kadar A; Kis E; Kristof E; Lupkovics G; Mark L; Nagy A; Nagy L; Poor F; Regos L; Sebo J; Tomcsányi J; Toth K; Bharani A; Chidambaram N; Haridas KK; Iyengar SS; Jain A; Jain A; Jain PRK; Jaison TM; Kerkar PG; Naik S; Nambiar A; Narendra J; Panwar RB; Parikh K; Puri VK; Rajesh T; Ramesh M; Singh B; Thanikachalam S; Tongia RK; Varma S; Barbiero M; Bardelli G; Bernardi D; Bolognese L; Capponi L; De Ferrari G; Fanelli R; Frediani L; Galli M; Izzo A; Lombardi A; Maresta A; Martinoni A; Melloni C; Meneghetti P; Mennuni M; Moretti L; Orlandi M; Pancaldi LG; Petronzelli S; Piovaccari G; Salvioni A; Severini D; Terrosu P; Zanini R; Erglis A; Kalnins U; Verboenko J; Zakke I; Kugiene R; Zaliunas R; Bin Othman A; Chee KH; Hian SK; Gutierrez AC; Diaz AC; Garcia-Castillo A; Guerrero MC; Morales CL; Ramos-López G; Baldew SC; Basart DCG; Clappers N; Daniels MCG; de Weerd GJ; den Hartog FR; Hendriks IHGM; Herrman JPR; Kofflard M; Krasznai K; Michels HR; Stoel I; ten Berg JM; Umans VAWN; van Beek GJ; van Daele MERM; van den Berg BJ; van Hessen MWJ; van Kalmthout PM; van Rossum P; Verheugt FWA; Viergever EP; Withagen AJAM; Achremczyk P; Arasimowicz P; Baranowska T; Biegayto J; Bronisz M; Buszman P; Czepiel A; Dalkowski M; Dluzniewski M; Gessek J; Goch JH; Gorecki A; Janik K; Janion M; Kawecki D; Kleinrok A; Komorowski P; Krasowski W; Krauze-Wielicka M; Malinowski S; Nowak T; Nowakowski P; Ogorek M; Piepiorka M; Pluta W; Puzio E; Puzniak M; Rekosz J; Rybka P; Sendrowski D; Siminiak T; Skura M; Stopinski M; Szetemej R; Szolkiewicz M; Szpajer M; Trusz-Gluza M; Waszyrowski T; Wita K; Wodniecki J; Wojewoda P; Zambrzycki J; Zielinski Z; Cardoso P; Carrageta DM; Ferreira D; Gomes MV; Santos L; Arkhipov M; Belousov Y; Charchoglyan R; Gordeev IG; Gratsiansky NA; Grinshtein Y; Khrustalev O; Kokorin VA; Komarov A; Kozulin V; Minushkina LO; Panchenko E; Panov A; Petrik ES; Shakhnovich RM; Shalaev SV; Sukhinina TS; Trifonov IR; Zateyshchikov DA; Khoo BCH; Tan HC; Tan RS; Hricak V; Motovska Z; Poliacik P; Kanic V; Kovacic D; Kranjec I; Voga G; Bayat J; Essop MR; Maritz F; Marx JD; Ntsekhe M; Pretorius MP; Ranjith N; Theron H; Chae IH; Chae SC; Choe KH; Chung NS; Jeong MH; Kim CJ; Kim HS; Kim W; Rhim CY; Shin EK; Shin GJ; Alameda M; Alonso-Orcajo N; Bethencourt A; Calvo F; Avellaneda JLC; Delgado V; Díaz-Castro O; Esplugas E; Faus R; Fernandez-Ortiz A; Frutos A; Goirena P; Heras M; Iglesias FC; Llorian AR; Macaya C; Mancisidor X; Melgares R; Pascual C; Ruiz-Nodar JM; Simon JM; Agewall S; Ahlström P; Ali M; Andersson L; Bandh S; Digerfeldt C; Ericsson H; Forsgren M; Jabro J; Janzon M; Joborn H; Johnston N; Karlsson JE; Larsson LE; Linderfalk C; Lönnberg I; Mooe T; Näslund U; Oldgren J; Pihl E; Risenfors M; Sjölund E; Söderberg I; Stjerna A; Svennberg L; Wodlin P; Pagnamenta A; Pieper M; Rossi MG; Weber K; Peng MC; Cheng JJ; Chiang FT; Kuo CT; Tseng CD; Andreyeshcheva I; Dzyak GV; Fedtchouk L; Gontar A; Karpenko O; Kononenko L; Koval EA; Kovalsky I; Kraitz I; Lutay Y; Netiazhenko V; Polyvoda S; Prokopenko Y; Prudkiy I; Rudenko L; Serediuk N; Zolotaykina V; Adgey J; Ahsan A; Brack M; Bridges AB; Burton J; Findlay I; Fluck DS; Radford L; Robson RH; Senior R; Starkey IR; Alexander J; Baber Z; Campbell M; Caputo R; Chandna H; Chandrashekhar Y; Chu A; DeRaad RE; Druken B; Goyal A; Holly D; Kemp A; Kotlaba D; Levine MJ; Miller GP; Nygaard T; Parikh DK; Ramos C; Rivera E; Rodriguez R; Sangani B; Walder JS
Article: HAEMOSTASIS. 2006;35(6):440-444
Association between AMPD1 gene polymorphism and coagulation factors in patients with coronary heart disease
Agewall S; Norman B
Article: KIDNEY INTERNATIONAL. 2006;69(1):178-183
Microalbuminuria in patients with previous myocardial infarction
Henareh L; Jogestrand T; Agewall S
Article: ATHEROSCLEROSIS. 2006;184(1):130-136
Endothelial function in conduit and resistance arteries in men with coronary disease
Agewall S; Henareh L; Kublickiene K
Article: DIABETIC MEDICINE. 2005;22(9):1212-1217
Glucose intolerance is associated with C-reactive protein and intima-media anatomy of the common carotid artery in patients with coronary heart disease
Henareh L; Jogestrand T; Agewall S
Article: JOURNAL OF HYPERTENSION. 2005;23(7):1397-1402
Morphological changes rather than flow-mediated dilatation in the brachial artery are better indicators of the extent and severity of coronary artery disease
Rohani M; Jogestrand T; Källner G; Jussila R; Agewall S
Article: ATHEROSCLEROSIS. 2005;179(2):311-316
Interrelation between the extent of atherosclerosis in the thoracic aorta, carotid intima-media thickness and the extent of coronary artery disease
Rohani M; Jogestrand T; Ekberg M; van der Linden J; Källner G; Jussila R; Agewall S
Article: CLINICAL CARDIOLOGY. 2005;28(2):77-80
The new definition of myocardial infaretion -: Can we use it?
Agewall S; Löwbeer C
Article: JOURNAL OF HYPERTENSION. 2005;23(1):119-125
Intima-media complex of both the brachial artery and the common carotid artery are associated with left ventricular hypertrophy in patients with previous myocardial infarction
Agewall S; Henareh L; Jogestrand T
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2004;24(6):317-322
Non-invasive assessment of endothelial function - relation between vasodilatory responses in skin microcirculation and brachial artery
Hansell J; Henareh L; Agewall S; Norman M
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2004;97(1):21-24
Should oral glucose tolerance test be a routine examination after a myocardial infarction?
Henareh L; Berglund M; Agewall S
Article: CLINICAL CARDIOLOGY. 2004;27(5):271-274
Reduced quality of life after myocardial infarction in women compared with men
Agewall S; Berglund M; Henareh L
Article: JOURNAL OF INTERNAL MEDICINE. 2004;255(3):379-383
Oral snuff impairs endothelial function in healthy snuff users
Rohani M; Agewall S
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2004;6(1):85-93
Effect of tissue harmonic imaging and contrast upon between observer and test-restest reproducibility of left ventricular ejection fraction measurement in patients with heart failure
Whalley GA; Gamble GD; Walsh HJ; Wright SR; Agewall S; Sharpe N; Doughty RN
Article: CLINICAL BIOCHEMISTRY. 2003;36(1):27-30
Evaluation of point-of-care test systems using the new definition of myocardial infarction
Agewall S
Article: ATHEROSCLEROSIS. 2002;164(1):161-166
Microalbuminuria and intima-media thickness of the carotid artery in clinically healthy men
Agewall S; Björn F
Article: CLINICAL CARDIOLOGY. 2002;25(6):287-290
Lipoprotein(a) was an independent predictor for major coronary events in treated hypertensive men.
Agewall S; Fagerberg B
Article: METABOLISM-CLINICAL AND EXPERIMENTAL. 2002;51(6):750-753
Urinary albumin excretion and insulin metabolism in clinically healthy 58-year-old men
Agewall S; Björn F
Journal article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2002;22(1):18-23
Post-occlusion brachial artery vasodilatation after ischaemic handgrip exercise is nitric oxide mediated
Agewall S; Hulthe J; Fagerberg B; Gottfridsson B; Wikstrand J
Article: BRITISH JOURNAL OF BIOMEDICAL SCIENCE. 2002;59(3):145-149
Smoking and use of smokeless tobacco in treated hypertensive men at high coronary risk: utility of urinary cotinine determination
Agewall S; Persson B; Lindstedt G; Fagerberg B
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2002;22(1):18-23
Post-occlusion brachial artery vasodilatation after ischaemic handgrip exercise is nitric oxide mediated
Agewall S; Hulthe J; Fagerberg B; Gottfridsson B; Wikstrand J
Article: ATHEROSCLEROSIS. 2001;157(1):197-202
Independent relationship between microalbuminuria and plasminogen activator inhibitor-1 activity (PAI-1) activity in clinically healthy 58-year-old men
Agewall S; Lindstedt G; Fagerberg B
Article: JOURNAL OF INTERNAL MEDICINE. 2001;249(4):305-314
Multiple risk intervention trial in high risk hypertensive men: comparison of ultrasound intima-media thickness and clinical outcome during 6 years of follow-up.
Agewall S; Fagerberg B; Berglund G; Schmidt C; Wendelhag I; Wikstrand J; Risk Factor Intervention Study Group, Sweden
Article: JOURNAL OF HUMAN HYPERTENSION. 2001;15(1):71-74
Should we do an oral glucose tolerance test in hypertensive men with normal tasting blood-glucose?
Agewall S
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2001;21(1):9-14
Comparison of ultrasound assessment of flow-mediated dilatation in the radial and brachial artery with upper and forearm cuff positions
Agewall S; Doughty RN; Bagg W; Whalley GA; Braatvedt G; Sharpe N
Article: THROMBOSIS AND HAEMOSTASIS. 2000;84(4):571-575
Insulin sensitivity and hemostatic factors in clinically healthy 58-year-old men
Agewall S; Bokemark L; Wikstrand J; Lindahl A; Fagerberg B
Article: STROKE. 2000;31(7):1526-1531
Chlamydia pneumoniae seropositivity is associated with carotid artery intima-media thickness
Schmidt C; Hulthe J; Wikstrand J; Gnarpe H; Gnarpe J; Agewall S; Fagerberg B
Article: EUROPEAN HEART JOURNAL. 2000;21(1):74-78
Does a glass of red wine improve endothelial function?
Agewall S; Wright S; Doughty RN; Whalley GA; Duxbury M; Sharpe N
Article: JOURNAL OF INTERNAL MEDICINE. 1999;246(5):489-495
Insulin sensitivity and haemostatic factors in men at high and low cardiovascular risk. The Risk Factor Intervention Study Group.
Agewall S
Article: HEART. 1999;82(1):93-95
Handgrip exercise increases postocclusion hyperaemic brachial artery dilatation
Agewall S; Whalley GA; Doughty RN; Sharpe N
Journal article: AMERICAN JOURNAL OF HYPERTENSION. 1999;12(S4):144a
E023: The metabolic syndrome in hypertensive men: High risk of cardiovascular disease that may be reduced.
Fagerberg B; Wikstrand J; Agewall S
Article: STROKE. 1999;30(2):299-305
Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease -: A prospective study in middle-aged to elderly men with treated hypertension
Fagerberg B; Gnarpe J; Gnarpe H; Agewall S; Wikstrand J
Article: STROKE. 1998;29(11):2329-2333
Stroke was predicted by dimensions of quality of life in treated hypertensive men.
Agewall S; Wikstrand J; Fagerberg B
Article: JOURNAL OF HYPERTENSION. 1998;16(4):537-541
Prothrombin fragment 1+2 is a risk factor for myocardial infarction in treated hypertensive men.
Agewall S; Wikstrand J; Fagerberg B
Article: AMERICAN JOURNAL OF HYPERTENSION. 1998;11(1):14-22
Mortality rates in treated hypertensive men with additional risk factors are high but can be reduced - A randomized intervention study
Fagerberg B; Wikstrand J; Berglund G; Samuelsson O; Agewall S
Article: AMERICAN JOURNAL OF CARDIOLOGY. 1997;80(2):164-169
Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group.
Agewall S; Wikstrand J; Ljungman S; Fagerberg B
Journal article: AMERICAN JOURNAL OF HYPERTENSION. 1997;10(S2):206a
L30: Stroke is predicted by dimensions of quality of life in treated hypertensive men
Agewall S; Wikstrand J; Fagerberg B
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 1996;26(11):960-965
Multifactorial treatment of hypertensive men at high cardiovascular risk and low-density lipoprotein cholesterol affinity to human arterial proteoglycans
Fagerberg B; Wiklund O; Agewall S; Camejo G; Wikstrand RJ
Article: ANGIOLOGY. 1996;47(10):963-972
Risk factors that predict development of microalbuminuria in treated hypertensive men
Agewall S; Fagerberg B
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 1996;16(8):971-977
Atherosclerotic disease in the femoral artery in hypertensive patients at high cardiovascular risk - The value of ultrasonographic assessment of intima-media thickness and plaque occurrence
Suurkula M; Fagerberg B; Wendelhag I; Agewall S; Wikstrand J
Article: AMERICAN JOURNAL OF HYPERTENSION. 1996;9(6):545-550
Negative feelings (discontent) predict progress of intima-media thickness of the common carotid artery in treated hypertensive men at high cardiovascular risk
Agewall S; Wikstrand J; Dahlof C; Fagerberg B
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 1996;16(3):462-470
Multiple risk intervention in high-risk hypertensive patients - A 3-year ultrasound study of intima-media thickness and plaques in the carotid artery
Suurkula M; Agewall S; Fagerberg B; Wendelhag I; Wikstrand J
Article: HAEMOSTASIS. 1996;26(1):45-57
Femoral artery wall morphology, hemostatic factors and intermittent claudication: Ultrasound study in men at high and low risk for atherosclerotic disease
Agewall S; Wikstrand J; Wendelhag I; Tengborn L; Fagerberg B
Article: JOURNAL OF HYPERTENSION. 1995;13(12):1471-1477
A randomized study of quality of life during multiple risk factor intervention in treated hypertensive men at high cardiovascular risk
Agewall S; Wikstrand J; Dahlof C; Fagerberg B
Article: STROKE. 1995;26(6):956-960
Carotid artery wall intima-media thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk.
Agewall S; Fagerberg B; Attvall S; Wendelhag I; Urbanavicius V; Wikstrand J
Journal article: AMERICAN JOURNAL OF HYPERTENSION. 1995;8(4_Pt_2):35a
Thursday, May 18, 12:15 pmLow general contentment is independently associated with progress of the intima-media thickness in the common carotid artery in treated hypertensive men.
Agewall S; Wikstrand J; Dahlöf C; Fagerberg B
Journal article: AMERICAN JOURNAL OF HYPERTENSION. 1995;8(4_Pt_2):188a
D9URINARY ALBUMIN EXCRETION IS ASSOCIATED WITH INTIMA-MEDIA THICKNESS OF THE CAROTID ARTERY IN HYPERTENSIVE MEN WITH NON-INSULIN-DEPENDENT DIABETES MELLITUS
Agewall S; Wikstrand J; Ljungman S; Fagerberg B
Article: JOURNAL OF HYPERTENSION. 1995;13(4):463-469
URINARY ALBUMIN EXCRETION IS ASSOCIATED WITH THE INTIMA MEDIA THICKNESS OF THE CAROTID-ARTERY IN HYPERTENSIVE MALES WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS
AGEWALL S; WIKSTRAND J; LJUNGMAN S; FAGERBERG B
Article: AMERICAN JOURNAL OF HYPERTENSION. 1995;8(4):337-342
DOES MICROALBUMINURIA PREDICT CARDIOVASCULAR EVENTS IN NONDIABETIC MEN WITH TREATED HYPERTENSION
AGEWALL S; WIKSTRAND J; LJUNGMAN S; HERLITZ H; FAGERBERG B
Article: JOURNAL OF INTERNAL MEDICINE. 1995;237(2):195-203
MICROALBUMINURIA, INSULIN SENSITIVITY AND HEMOSTATIC FACTORS IN NONDIABETIC TREATED HYPERTENSIVE MEN
AGEWALL S; FAGERBERG B; ATTVALL S; LJUNGMAN S; URBANAVICIUS V; TENGBORN L; WIKSTRAND J
Article: JOURNAL OF INTERNAL MEDICINE. 1995;237(1):19-26
THE COST-EFFECTIVENESS OF A CARDIOVASCULAR MULTIPLE-RISK-FACTOR INTERVENTION PROGRAM IN TREATED HYPERTENSIVE MEN
JOHANNESSON M; AGEWALL S; HARTFORD M; HEDNER T; FAGERBERG B
Journal article: JOURNAL OF INTERNAL MEDICINE. 1994;236(6):651-659
THE EFFICACY OF MULTIPLE RISK FACTOR INTERVENTION IN TREATED HYPERTENSIVE MEN DURING LONG-TERM FOLLOW-UP
AGEWALL S; WIKSTRAND J; SAMUELSSON O; PERSSON B; ANDERSSON OK; FAGERBERG B
Journal article: BLOOD COAGULATION & FIBRINOLYSIS. 1994;5(6):895-904
CAROTID-ARTERY WALL MORPHOLOGY, HEMOSTATIC FACTORS AND CARDIOVASCULAR-DISEASE - AN ULTRASOUND STUDY IN MEN AT HIGH AND LOW-RISK FOR ATHEROSCLEROTIC DISEASE
AGEWALL S; WIKSTRAND J; SUURKULA M; TENGBORN L; FAGERBERG B
Journal article: CLINICAL CHEMISTRY. 1994;40(11 Pt 1):2057-2063
Is carbohydrate-deficient transferrin in serum useful for detecting excessive alcohol consumption in hypertensive patients?
Fagerberg B; Agewall S; Berglund A; Wysocki M; Lundberg PA; Lindstedt G
Journal article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1994;79(3):712-715
CARBOHYDRATE-DEFICIENT TRANSFERRIN IS ASSOCIATED WITH INSULIN SENSITIVITY IN HYPERTENSIVE MEN
FAGERBERG B; AGEWALL S; URBANAVICIUS V; ATTVALL S; LUNDBERG PA; LINDSTEDT G
Journal article: ARTERIOSCLEROSIS AND THROMBOSIS. 1994;14(8):1297-1304
ULTRASOUND EVALUATION OF ATHEROSCLEROTIC MANIFESTATIONS IN THE CAROTID-ARTERY IN HIGH-RISK HYPERTENSIVE PATIENTS
SUURKULA M; AGEWALL S; FAGERBERG B; WENDELHAG I; WIDGREN B; WIKSTRAND J
Journal article: JOURNAL OF HYPERTENSION. 1993;11(4):461-469
MICROALBUMINURIA IN TREATED HYPERTENSIVE MEN AT HIGH-RISK OF CORONARY-DISEASE
AGEWALL S; PERSSON B; SAMUELSSON O; LJUNGMAN S; HERLITZ H; FAGERBERG B
Journal article: NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES. 1993;3(3):128-135
MULTIPLE CARDIOVASCULAR RISK FACTOR INTERVENTION IN TREATED HYPERTENSIVE MEN - WHAT CAN BE ACHIEVED
AGEWALL S; FAGERBERG B; SAMUELSSON O; PERSSON B; HEDNER T; ANDERSSON OK; WIKSTRAND J; BERGLUND G
Journal article: JOURNAL OF INTERNAL MEDICINE. 1991;229(2):151-158
REFLEXOGENIC NEURONAL AND HUMORAL RESPONSES TO SELECTIVE STIMULATION OF LOW-PRESSURE CARDIOPULMONARY RECEPTORS IN MAN
AGEWALL S; RHEA B; PERSSON B; KARLBERG B; WALLIN G; ANDERSSON OK
Journal article: JOURNAL OF HYPERTENSION. 1989;7(9):747-756
ADRENALINE INFUSION IN MAN INCREASES MUSCLE SYMPATHETIC-NERVE ACTIVITY AND NORADRENALINE OVERFLOW TO PLASMA
PERSSON B; ANDERSSON OK; HJEMDAHL P; WYSOCKI M; AGERWALL S; WALLIN G
Journal article: JOURNAL OF HYPERTENSION. 1988;6(4):s741
115 Adrenaline-induced increases in plasma noradrenaline in man are due to an increased nerve activity rather than to prejunctional modulation of transmitter release
Andersson OK; Hjemdahl P; Persson B; Wysocki M; Agewall S; Wallin G
Visa fler

Alla övriga publikationer

Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2024;10(7):614-645
Update on antithrombotic therapy and body mass: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the European Society of Cardiology Working Group on Thrombosis
Gigante B; Tamargo J; Agewall S; Atar D; ten Berg J; Campo G; Cerbai E; Christersson C; Dobrev D; Ferdinandy P; Geisler T; Gorog DA; Grove EL; Kaski JC; Rubboli A; Wassmann S; Wallen H; Rocca B
Review: CIRCULATION-CARDIOVASCULAR IMAGING. 2024;17(7):e016463
How to Use Cardiac Magnetic Resonance Imaging in Myocardial Infarction With Nonobstructive Coronary Arteries
Tornvall P; Beltrame JF; Nickander J; Soerensson P; Reynolds HR; Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2024;10(3):171-172
Oral anticoagulants and antiplatelet treatment in different settings
Agewall S
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2024;10(3):219-244
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023
Tamargo J; Agewall S; Borghi C; Ceconi C; Cerbai E; Dan GA; Ferdinandy P; Grove EL; Rocca B; Magavern E; Sulzgruber P; Semb AG; Sossalla S; Niessner A; Kaski JC; Dobrev D
Review: CIRCULATION RESEARCH. 2024;134(9):1098-1112
Heat and Cardiovascular Mortality: An Epidemiological Perspective
Singh N; Areal AT; Breitner S; Zhang S; Agewall S; Schikowski T; Schneider A
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2024;10(2):83-84
New data on NOVEL ORAL ANTICOAGULANT, SGLT2i, lipid treatment and genetics
Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2024;10(1):1-2
Cardiovascular prevention and risk factors
Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2023;9(8):671-672
The search for the perfect antiplatelet treatment continues
Agewall S
Letter: JACC-CARDIOVASCULAR IMAGING. 2023;16(12):1626-1628
CMR Is Often Abnormal Despite Normal Echocardiography in Suspected Myocardial Infarction With Nonobstructed Coronary Arteries
Sundqvist MG; Sorensson P; Ekenback C; Lundin M; Agewall S; Brolin EB; Cederlund K; Collste O; Daniel M; Jensen J; Y-Hassan S; Henareh L; Hofman-Bang C; Lynga P; Maret E; Sarkar N; Spaak J; Winnberg O; Caidahl K; Ugander M; Tornvall P
Editorial comment: EUROPEAN HEART JOURNAL. 2023;44(42):4485-4487
Concerns about aortic aneurysm or dissection risk should not cease fluoroquinolone use when clinically indicated
Tamargo J; Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2023;9(7):593-594
Antiplatelet treatment after PCI
Agewall S
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2023;9(6):570-582
Triglycerides revisited: is hypertriglyceridaemia a necessary therapeutic target in cardiovascular disease?
Drexel H; Tamargo J; Kaski JC; Lewis BS; Saely CH; Fraunberger P; Dobrev D; Komiyama M; Plattner T; Agewall S; Hasegawa K
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2023;9(6):497-498
Cardiovascular preventive actions
Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2023;9(5):401-402
Atrial fibrillation has gone from a boring disease to a very hot condition. Why is that?
Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2023;9(4):pvad037-296
Focus on prevention in diabetes mellitus and lipid disorder
Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2023;9(3):199-200
A tailor-made suit always fits best
Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2023;9(2):121
Fibrates: one more lost paradise in lipid treatment
Drexel H; Saely CH; Agewall S
Letter: JACC-CARDIOVASCULAR IMAGING. 2023;16(1):128-129
Comprehensive Follow-Up Cardiac Magnetic Resonance of Patients With Myocardial Infarction With Nonobstructive Coronary Arteries
Nickander J; Ekenback C; Agewall S; Brolin EB; Caidahl K; Cederlund K; Collste O; Daniel M; Jensen J; Y-Hassan S; Henareh L; Hofman-Bang C; Lynga P; Maret E; Sarkar N; Spaak J; Winnberg O; Sundqvist M; Ugander M; Tornvall P; Sorensson P
Preprint: MEDRXIV. 2022
Cardiovascular magnetic resonance imaging after normal echocardiography in myocardial infarction with nonobstructed coronary arteries
Sundqvist M; Sörensson P; Ekenbäck C; Lundin M; Agewall S; Bacsovics Brolin E; Cederlund K; Collste O; Daniel M; Jensen J; Y-Hassan S; Henareh L; Hofman-Bang C; Lyngå P; Maret E; Sarkar N; Spaak J; Winnberg O; Caidahl K; Ugander M; Tornvall P
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(7):645-647
Treating patients with anticoagulants and antiplatelet drugs is always a balance between risk for thrombosis vs. risk for bleeding
Agewall S
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(7):738-751
Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events
Tamargo J; Kaski JC; Kimura T; Barton JC; Yamamoto K; Komiyama M; Drexel H; Lewis BS; Agewall S; Hasegawa K
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(5):e25
Future of antithrombotic therapy for heart failure with coronary artery disease
Komiyama M; Agewall S; Hasegawa K
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(4):406-419
Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Tamargo J; Kjeldsen KP; Delpon E; Semb AG; Cerbai E; Dobrev D; Savarese G; Sulzgruber P; Rosano G; Borghi C; Wassman S; Torp-Pedersen CT; Agewall S; Drexel H; Baumgartner I; Lewis B; Ceconi C; Kaski JC; Niessner A
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(3):302-310
Subgroup analyses in randomized clinical trials: value and limitations. Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy
Drexel H; Pocock SJ; Lewis BS; Saely CH; Kaski JC; Rosano GMC; Tautermann G; Huber K; Dopheide JF; Mader A; Niessner A; Savarese G; Schmidt TA; Semb AG; Tamargo J; Wassmann S; Clodi M; Kjeldsen KP; Agewall S
Review: CLINICAL RESEARCH IN CARDIOLOGY. 2022;111(4):428-439
Influence of receptor selectivity on benefits from SGLT2 inhibitors in patients with heart failure: a systematic review and head-to-head comparative efficacy network meta-analysis.
Täger T; Frankenstein L; Atar D; Agewall S; Frey N; Grundtvig M; Clark AL; Cleland JGF; Fröhlich H
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(2):187-210
Potentially inappropriate prescriptions in heart failure with reduced ejection fraction: ESC position statement on heart failure with reduced ejection fraction-specific inappropriate prescribing
El Hadidi S; Rosano G; Tamargo J; Agewall S; Drexel H; Kaski JC; Niessner A; Lewis BS; Coats AJS; Savarese G
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(1):85-99
The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Magavern EF; Kaski JC; Turner RM; Drexel H; Janmohamed A; Scourfield A; Burrage D; Floyd CN; Adeyeye E; Tamargo J; Lewis BS; Kjeldsen KP; Niessner A; Wassmann S; Sulzgruber P; Borry P; Agewall S; Semb AG; Savarese G; Pirmohamed M; Caulfield MJ
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2021;7(6):557-567
Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: a review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Krogager ML; Kragholm K; Thomassen JQ; Sogaard P; Lewis BS; Wassmann S; Baumgartner I; Ceconi C; Schmidt TA; Kaski JC; Drexel H; Semb AG; Agewall S; Niessner A; Savarese G; Kjeldsen KP; Borghi C; Tamargo J; Torp-Pedersen C
Review: HEART FAILURE REVIEWS. 2021;26(6):1421-1435
Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials
Taeger T; Atar D; Agewall S; Katus HA; Grundtvig M; Cleland JGF; Clark AL; Froehlich H; Frankenstein L
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2021;7(5):453-459
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid, diabetes, and antithrombotic trials
Drexel H; Lewis BS; Rosano GMC; Saely CH; Tautermann G; Huber K; Dopheide JF; Kaski JC; Mader A; Niessner A; Savarese G; Schmidt TA; Semb A; Tamargo J; Wassmann S; Kjeldsen KP; Agewall S; Pocock SJ
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2021;7(2):81-82
Antiplatelet treatment in coronary syndrome
Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2021;7(1):1-2
Atrial fibrillation in registries
Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2020;6(6):339-340
Focus on blood pressure and risk factor intervention
Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2020;6(5):271-272
Minimizing bleeding events
Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2020;6(5):284
MSc in clinical trials: a new flagship Working Group project
Lewis BS; Agewall S; Rosano GMC
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2020;6(4):201-202
Can we offer tailor-made pharmacological treatment of patients with acute coronary syndrome?
Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2020;6(3):131-132
Focus on subpopulations of atrial fibrillation patients
Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2020;6(2):71
Lipids and antithrombotic treatment
Agewall S
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2020;6(2):104-114
Lipid management in rheumatoid arthritis: a position paper of the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology
Hollan I; Ronda N; Dessein P; Agewall S; Karpouzas G; Tamargo J; Niessner A; Savarese G; Rosano G; Kaski JC; Wassmann S; Meroni PL
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2020;6(2):86-93
Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases
Savarese G; Reiner MF; Uijl A; D'Amario D; Agewall S; Atar D; Baumgartner I; Borghi C; De Carlo M; Drexel H; Kaski JC; Kjeldsen KP; Kucher N; Lund LH; Niessner A; Semb AG; Schmidt TA; Sulzgruber P; Tamargo J; Vitale C; Wassmann S; Aboyans V; Lewis BS
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2020;6(2):97-103
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid and diabetes trials
Drexel H; Rosano GMC; Lewis BS; Huber K; Vonbank A; Dopheide JF; Mader A; Niessner A; Savarese G; Wassmann S; Agewall S
Review: EUROPEAN HEART JOURNAL. 2020;41(3):407-477
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)
Knuuti J; Wijns W; Saraste A; Capodanno D; Barbato E; Funck-Brentano C; Prescott E; Storey RF; Deaton C; Cuisset T; Agewall S; Dickstein K; Edvardsen T; Escaned J; Gersh BJ; Svitil P; Gilard M; Hasdai D; Hatala R; Mahfoud F; Masip J; Muneretto C; Valgimigli M; Achenbach S; Bax JJ; Neumann F-J; Sechtem U; Banning AP; Bonaros N; Bueno H; Bugiardini R; Chieffo A; Crea F; Czerny M; Delgado V; Dendale P
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2020;22:50
Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for mortality in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials
Froehlich H; Taeger T; Atar D; Agewall S; Katus HA; Grundtvig M; Cleland JGF; Clark A; Frankenstein L
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2020;6(1):1-2
Focus on pharma in acute coronary syndrome
Agewall S
Editorial comment: CARDIOVASCULAR RESEARCH. 2019;115(14):e187-e188
Medical misinformation: vet the message!
Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol Ç; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Lüscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Review: CARDIAC FAILURE REVIEW. 2019;5(3):130-132
Hyperkalemia and Renin-Angiotensin-Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction.
Rosano GM; Spoletini I; Vitale C; Agewall S
Corrigendum: EUROPEAN HEART JOURNAL. 2019;40(37):3096
2018 ESC/EACTS Guidelines onmyocardial revascularization (vol 40, pg 87, 2019)
Neumann FJ; Sousa-Uva M; Ahlsson A; Alfonso F; Banning AP; Benedetto U; Byrne RA; Collet JP; Falk V; Head SJ; Juni P; Kastrati A; Koller A; Kristensen SD; Niebauer J; Richter DJ; Seferovic PM; Sibbing D; Stefanini GG; Windecker S; Yadav R; Zembala MO; Wijns W; Glineur D; Aboyans V; Agewall S; Andreotti F; Barbato E; Baumbach A; Brophy J; Bueno H; Calvert PA; Capodanno D; Davierwala PM; Delgado V; Dudek D; Freemantle N; Funck-Brentano C; Gaemperli O; Gielen S; Gilard M; Gorenek B; Haasenritter J; Haude M; Ibanez B; Iung B; Jeppsson A; Katritsis D; Knuuti J; Kolh P; Leite-Moreira A; Lund LH; Maisano F; Mehilli J; Metzler B; Montalescot G; Pagano D; Petronio AS; Piepoli MF; Popescu BA; Sadaba R; Shlyakhto E; Silber S; Simpson IA; Sparv D; Tavilla G; Thiele H; Tousek P; Van Belle E; Vranckx P; Witkowski A; Zamorano JL; Roffi M; Windecker S; Aboyans V; Agewall S; Barbato E; Bueno H; Coca A; Collet JP; Coman IM; Dean V; Delgado V; Fitzsimons D; Gaemperli O; Hindricks G; Iung B; Juni P; Katus HA; Knuuti J; Lancellotti P; Leclercq C; McDonagh TA; Piepoli MF; Ponikowski P; Richter DJ; Roffi M; Shlyakhto E; Sousa-Uva M; Simpson IA; Zamorano JL; Pagano D; Freemantle N; Sousa-Uva M; Chettibi M; Sisakian H; Metzler B; Ibrahimov F; Stelmashok VI; Postadzhiyan A; Skoric B; Eftychiou C; Kala P; Terkelsen CJ; Magdy A; Magdy A; Niemela M; Kedev S; Motreff P; Aladashvili A; Mehilli J; Kanakakis IG; Becker D; Gudnason T; Peace A; Romeo F; Bajraktari G; Kerimkulova A; Rudzitis A; Ghazzal Z; Kibarskis A; Pereira B; Xuereb RG; Hofma SH; Steigen TK; Witkowski A; de OEI; Mot S; Duplyakov D; Zavatta M; Beleslin B; Kovar F; Bunc M; Ojeda S; Witt N; Jeger R; Addad F; Akdemir R; Parkhomenko A; Henderson R
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2019;5(4):183-184
European Heart Journal - Cardiovascular Pharmacotherapy has received its first Impact Factor of 6.723
Agewall S
Editorial comment: EUROPEAN HEART JOURNAL. 2019;40(36):3010-3012
Oral Anticoagulation in patients with non-valvular atrial fibrillation and a CHA₂DS₂-VASc score of 1 A current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke
Sulzgruber P; Wassmann S; Semb AG; Doehner W; Widimsky P; Gremmel T; Kaski JC; Savarese G; Rosano GMC; Borghi C; Kjeldsen K; Torp-Pedersen C; Schmidt TA; Lewis BS; Drexel H; Tamargo J; Atar D; Agewall S; Niessner A
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2019;5(3):125-126
Antiplatelet treatment in acute coronary syndrome. Still an issue
Agewall S
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2019;5(3):171-180
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA₂DS₂-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke
Sulzgruber P; Wassmann S; Semb AG; Doehner W; Widimsky P; Gremmel T; Kaski JC; Savarese G; Rosano GMC; Borghi C; Kjeldsen K; Torp-Pedersen C; Schmidt TA; Lewis BS; Drexel H; Tamargo J; Atar D; Agewall S; Niessner A
Editorial comment: CARDIOVASCULAR DRUGS AND THERAPY. 2019;33(3):275-276
Medical Misinformation: Vet the Message!
Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol C; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Luscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Editorial comment: JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY. 2019;55(1):1-3
Medical misinformation: vet the message!
Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol C; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Luscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SLV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2019;78:1628.3-161629
ANTIRHEUMATIC THERAPY IS NOT ASSOCIATED WITH CHANGES IN CIRCULATING N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE (NT-PROBNP) LEVELS IN PATIENTS WITH RHEUMATOID ARTHRITIS
Thao N; Deyab G; Fagerland M; Agewall S; Eilertsen G; Feinberg M; Mikkelsen K; Forre O; Hollan I
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2019;5(2):59
European Heart Journal - Cardiovascular Pharmacotherapy: now accepted for an official Impact Factor
Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2019;5(2):60-61
Unsolved issues in oral anticoagulation treatment in atrial fibrillation
Agewall S
Letter: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2019;5(2):119-121
Ivabradine for heart failure: regulatory differences in Europe and United States
Marciniak TA; Hall TS; Atar D; Agewall S; Serebruany VL
Editorial comment: EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES. 2019;5(2):83-84
Medicalmisinformation: vet the message!
Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol C; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Luscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2019;5(2):62-63
Medical misinformation: vet the message!
Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol C; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Luscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Editorial comment: JOURNAL OF ELECTROCARDIOLOGY. 2019;53:112-113
Medical misinformation: Vet the message!
Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol C; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Luscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Editorial comment: HEART RHYTHM. 2019;16(3):332-333
Medical misinformation: Vet the message!
Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol C; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Luscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Editorial comment: HYPERTENSION. 2019;73(3):506-507
Medical Misinformation Vet the Message!
Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol C; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Luscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Other: EUROPEAN JOURNAL OF HEART FAILURE. 2019;21(3):264-265
Medical misinformation: vet the message!
Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol C; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Luscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Editorial comment: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2019;277:1-2
Medical Misinformation: Vet the Message!
Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol C; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Luscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Editorial comment: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2019;8(3):e011838
Medical Misinformation: Vet the Message!
Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol C; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Luscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Editorial comment: EUROPEAN HEART JOURNAL. 2019;40(5):404-405
Medical Misinformation: Vet the Message!
Hill JA; following HEART Group Signatories; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol Ç; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Lüscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Editorial comment: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2019;73(2):61-62
Medical Misinformation: Vet the Message!
Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol C; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Luscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Editorial comment: CIRCULATION-CARDIOVASCULAR INTERVENTIONS. 2019;12(2):e007796
Medical Misinformation Vet the Message!
Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol C; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Luscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Editorial comment: CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES. 2019;12(2):e005496
Medical Misinformation Vet the Message!
Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol C; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Luscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Editorial comment: CIRCULATION-CARDIOVASCULAR IMAGING. 2019;12(2):e008809
Medical Misinformation Vet the Message!
Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol C; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Luscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Editorial comment: CIRCULATION-GENOMIC AND PRECISION MEDICINE. 2019;12(2):e002439
Medical Misinformation Vet the Message!
Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol C; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Luescher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Editorial comment: CIRCULATION-HEART FAILURE. 2019;12(2):e005869
Medical Misinformation Vet the Message!
Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol C; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Luescher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Editorial comment: CIRCULATION. 2019;139(5):571-572
Medical Misinformation: Vet the Message!
Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol C; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Luscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2019;21:423-424
Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis
Frankenstein LL; Froehlich H; Grundtvig M; Seiz M; Schellberg D; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2019;21:55
Epidemiology and long-term outcome in outpatients with chronic heart failure in north-western europe
Froehlich H; Rosenfeld N; Taeger T; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L; Grundtvig M
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2019;71
Antirheumatic Therapy Is Associated with Reduced Complement Activation in Rheumatoid Arthritis
Thao N; Hokstad I; Deyab G; Mollnes TE; Agewall S; Fagerland M; Eilertsen G; Feinberg M; Mikkelsen K; Forre O; Hollan I
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2019;71
Antirheumatic Therapy Is Not Associated with Changes in Circulating N-terminal Pro-brain Natriuretic Peptide Levels in Patients with Active Rheumatoid Arthritis
Thao N; Deyab G; Fagerland M; Agewall S; Eilertsen G; Feinberg M; Mikkelsen K; Forre O; Hollan I
Editorial comment: CARDIOLOGY. 2019;142(2):63-65
Medical Misinformation: Vet the Message!
Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol C; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Luscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2019;5(1):1-2
Old and new drugs in cardiovascular pharmacotherapy
Agewall S
Corrigendum: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2019;5(1):36
Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a review (vol 4, pg 230, 2018)
Vonbank A; Drexel H; Agewall S; Lewis BS; Dopheide JF; Kjeldsen K; Ceconi C; Savarese G; Rosano G; Wassmann S; Niessner A; Schmidt TA; Saely CH; Baumgartner I; Tamargo J
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2019;5(1):47-54
Baseline low-density lipoprotein cholesterol to predict the extent of cardiovascular benefit from lipid-lowering therapies: a review
Navarese EP; Andreotti F; Raggi P; Kolodziejczak M; Buffon A; Bliden K; Tantry U; Kubica J; Sardella G; Lauten A; Agewall S; Gurbel PA; Brouwer MA
Review: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2018;272:260-266
Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction
Hall TS; von Lueder TG; Zannad F; Rossignol P; Duarte K; Chouihed T; Dickstein K; Atar D; Agewall S; Girerd N
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2018;4(4):191-192
Critical appraisal of the COMPASS trial
Niessner A; Agewall S
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2018;4(4):230-236
Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a review
Vonbank A; Drexel H; Agewall S; Lewis BS; Dopheide JF; Kjeldsen K; Ceconi C; Savarese G; Rosano G; Wassmann S; Niessner A; Schmidt TA; Saely CH; Baumgartner I; Tamargo J
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2018;4(4):189-190
Adherence to guidelines, compliance to treatment, and treatment quality
Agewall S
Review: EUROPEAN HEART JOURNAL. 2018;39(33):3021-3104
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams B; Mancia G; Spiering W; Rosei EA; Azizi M; Burnier M; Clement DL; Coca A; de Simone G; Dominiczak A; Kahan T; Mahfoud F; Redon J; Ruilope L; Zanchetti A; Kerins M; Kjeldsen SE; Kreutz R; Laurent S; Lip GYH; McManus R; Narkiewicz K; Ruschitzka F; Schmieder RE; Shlyakhto E; Tsioufis C; Aboyans V; Desormais I
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2018;4(3):129-130
New input on antiplatelet treatment and registry studies
Agewall S
Corrigendum: EUROPEAN HEART JOURNAL. 2018;39(21):1991
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation (vol 39, pg 119, 2017)
Ibanez B; James S; Agewall S; Antunes MJ; Bucciarelli-Ducci C; Bueno H; Caforio ALP; Crea F; Goudevenos JA; Halvorsen S; Hindricks G; Kastrati A; Lenzen MJ; Prescott E; Roffi M; Valgimigli M; Varenhorst C; Vranckx P; Widimsky P
Editorial comment: JOURNAL OF THORACIC DISEASE. 2018;10(Suppl 17):S1934-S1937
The burden of heart failure in the general population: a clearer and more concerning picture
von Lueder TG; Agewall S
Corrigendum: EUROPACE. 2018;20(5):738
Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP) (vol 20, pg 731, 2018)
Dan G-A; Martinez-Rubio A; Agewall S; Boriani G; Borggrefe M; Gaita F; van Gelder I; Gorenek B; Kaski JC; Kjeldsen K; Lip GYH; Merkely B; Okumura K; Piccini JP; Potpara T; Poulsen BK; Saba M; Savelieva I; Tamargo JL; Wolpert C
Editorial comment: JOURNAL OF MAMMALOGY. 2018;99(2):305
Editor's Choice
Editorial comment: EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY. 2018;55(4):457-464
Questions and Answers on Diagnosis and Management of Patients with Peripheral Arterial Diseases: A Companion Document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).
Aboyans V; Björck M; Brodmann M; Collet J-P; Czerny M; De Carlo M; Naylor AR; Roffi M; Tendera M; Vlachopoulos C; Ricco J-B; Task Force for the 2017 ESC Guidelines for the dia; Document Reviewers; Widimsky P; Kolh P; Dick F; Vega de Ceniga M; Piepoli MF; Sievert H; Sulzenko J; Esc Committee For Practice Guidelines Cpg; Windecker S; Aboyans V; Agewall S; Barbato E; Bueno H; Coca A; Collet J-P; Coman IM; Dean V; Delgado V; Fitzsimons D; Gaemperli O; Hindricks G; Iung B; Jüni P; Katus HA; Knuuti J; Lancellotti P; Leclercq C; McDonagh T; Piepoli MF; Ponikowski P; Richter DJ; Roffi M; Shlyakhto E; Simpson IA; Zamorano JL
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2018;4(2):65-66
Cardiovascular pharmacotherapy and real-world data
Agewall S
Editorial comment: EUROPEAN HEART JOURNAL. 2018;39(9):e35-e41
Questions and answers on diagnosis and management of patients with Peripheral Arterial Diseases: a companion document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
Aboyans V; Bjorck M; Brodmann M; Collet J-P; Czerny M; De Carlo M; Naylor AR; Roffi M; Tendera M; Vlachopoulos C; Ricco J-B; El Bartelink M-L; Cohnert T; Debus S; Espinola-Klein C; Kahan T; Kownator S; Mazzolai L; Roether J; Sprynger M; Tepe G; Venermo M; Desormais I
Editorial comment: SCANDINAVIAN CARDIOVASCULAR JOURNAL. 2018;52(1):1-3
Impact of climate and air pollution on acute coronary syndromes: an update from the European Society of Cardiology Congress 2017
Kaluzna-Oleksy M; Aunan K; Rao-Skirbekk S; Kjellstrom T; Ezekowitz JA; Agewall S; Atar D
Conference publication: EUROPEAN HEART JOURNAL. 2018;39:1344
Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction
Hall TS; Von Lueder TG; Zannad F; Rossignol P; Duarte K; Chouihed T; Dickstein K; Atar D; Agewall S; Girerd N
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2018;20:442
Relative efficacy of spironolactone, eplerenone, and canrenone in patients with chronic systolic heart failure - a systematic review and network meta-analysis of randomized controlled trials
Frankenstein LL; Taeger T; Froehlich H; Cleland JGF; Grundtvig M; Hole T; Katus H; Agewall S; Clark A; Atar D
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2018;20:88
Comparative effectiveness of enalapril, lisinopril and ramipril in the treatment of patients with chronic heart failure. A propensity score matched cohort study
Taeger TT; Henning F; Froehlich H; Schellberg D; Grundtvig M; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark A; Frankenstein L
Conference publication: EUROPEAN HEART JOURNAL. 2018;39:380
Deaths and vascular outcomes with non-vitamin K oral anticoagulants versus warfarin in patients with heart failure in the food and drug administration adverse event reporting system
Von Lueder TA; Atar D; Agewall S; Jensen J; Hopper I; Kotecha D; Mentz R; Serebruany VL
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2018;4(1):1
Cardiovascular pharmacotherapy
Agewall S
Letter: TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING. 2017;137(23-24)
«Falskt positive troponinverdier» finnes ikke.
Atar D; Agewall S
Editorial comment: EUROPEAN HEART JOURNAL. 2017;38(44):3251
European Heart Journal - Cardiovascular Pharmacotherapy
Agewall S
Corrigendum: EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. 2017;52(4):832
2017 ESC/EACTS Guidelines for the management of valvular heart disease (vol 52, pg 616, 2017))
Falk V; Baumgartner H; Bax JJ; De Bonis M; Hamm C; Holm PJ; Iung B; Lancellotti P; Lansac E; Rodriguez Munoz D; Rosenhek R; Sjogren J; Mas PT; Vahanian A; Walther T; Wendler O; Windecker S; Luis Zamorano J; Roffi M; Alfieri O; Agewall S; Ahlsson A; Barbato E; Bueno H; Collet J-P; Coman IM; Czerny M; Delgado V; Fitzsimons D; Folliguet T; Gaemperli O; Habib G; Harringer W; Haude M; Hindricks G; Katus HA; Knuuti J; Kolh P; Leclercq C; McDonagh TA; Piepoli MF; Pierard LA; Ponikowski P; Rosano GMC; Ruschitzka F; Shlyakhto E; Simpson IA; Sousa-Uva M; Stepinska J; Tarantini G; Tchetche D; Aboyans V
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2017;3(4):183-184
Adherence to guidelines and registry data
Agewall S
Review: EUROPEAN HEART JOURNAL. 2017;38(36):2739-2791
2017 ESC/EACTS Guidelines for the management of valvular heart disease The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
Baumgartner H; Falk V; Bax JJ; De Bonis M; Hamm C; Holm PJ; Iung B; Lancellotti P; Lansac E; Rodriguez Munoz D; Rosenhek R; Sjogren J; Tornos Mas P; Vahanian A; Walther T; Wendler O; Windecker S; Luis Zamorano J; Windecker S; Aboyans V; Agewall S; Barbato E; Bueno H; Coca A; Collet J-P; Coman IM; Dean V; Delgado V; Fitzsimons D; Gaemperli O; Hindricks G; Iung B; Juni P; Katus HA; Knuuti J; Lancellotti P; Leclercq C; McDonagh T; Piepoli MF; Ponikowski P; Richter DJ; Roffi M; Shlyakhto E; Simpson IA; Zamorano JL; Kzhdryan HK; Mascherbauer J; Samadov F; Shumavets V; Van Camp G; Loncar D; Lovric D; Georgiou GM; Linhartova K; Ihlemann N; Abdelhamid M; Pern T; Turpeinen A; Srbinovska-Kostovska E; Cohen A; Bakhutashvili Z; Ince H; Vavuranakis M; Temesvari A; Gudnason T; Mylotte D; Kuperstein R; Indolfi C; Pya Y; Bajraktari G; Kerimkulova A; Rudzitis A; Mizariene V; Lebrun F; Demarco DC; Oukerraj L; Bouma BJ; Steigen TK; Komar M; De Moura Branco LM; Popescu BA; Uspenskiy V; Foscoli M; Jovovic L; Simkova I; Bunc M; Vazquez de Prada JA; Stagmo M; Kaufmann BA; Mahdhaoui A; Bozkurt E; Nesukay E; Brecker SJD
Editorial comment: JOURNAL OF THORACIC DISEASE. 2017;9(7):1851-1854
Morphine in acute heart failure
Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2017;3(3):125-126
Metabolic control, anticoagulation, and gender aspects
Agewall S
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2017;3(3):163-182
Gender differences in the effects of cardiovascular drugs
Tamargo J; Rosano G; Walther T; Duarte J; Niessner A; Kaski JC; Ceconi C; Drexel H; Kjeldsen K; Savarese G; Torp-Pedersen C; Atar D; Lewis BS; Agewall S
Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2017;76:1309-1310
CELL CHOLESTEROL TRANSPORT IN SPONDYLOARTHRITIDES AND ITS RESPONSE TO ANTI-RHEUMATIC DRUGS
Ronda N; Hokstad I; Deyab G; Greco D; Agewall S; Hjeltnes G; Whist JE; Bernini F; Hollan I
Letter: EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2017;40:e11-e12
New-onset atrial fibrillation after percutaneous coronary intervention with stent: Updated proposal of an algorithm for the choice of oral anticoagulant and its dose
Rubboli A; Agewall S; Huber K; Lip GYH
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2017;3(2):69-70
Coronary artery disease and arrhythmias
Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2017;3(2):71-72
New ESC/EACTS Guidelines for the management of atrial fibrillation
Agewall S; Camm J
Conference publication: CIRCULATION. 2017;136
Influence of Left Ventricular Ejection Fraction on Fatal Outcomes After Myocardial Infarction Complicated by Heart Failure or Left Ventricular Dysfunction
Hall TS; von Lueder TG; Zannad F; Rossignol P; Duarte K; Chouihed T; Dickstein K; Atar D; Agewall S; Girerd N
Conference publication: EUROPEAN HEART JOURNAL. 2017;38:911
Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status
Agewall S; Tjessum L; Rossignol P; Zannad F; Atar D; Von Lueder T; Lamiral Z; Machu JL; Kjekshus J; Girerd N
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2017;19:289
Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure
Froehlich HH; Torres L; Taeger T; Schellberg D; Corletto A; Kazmi S; Goode K; Grundtvig M; Hole T; Katus HA; Cleland JGF; Atar D; Clark AL; Agewall S; Frankenstein L
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2017;3(1):1-2
Anticoagulation, atherosclerosis, and heart failure
Agewall S
Letter: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2016;224:412-415
Cardiovascular pharmacotherapy
Agewall S; Lewis BS; Atar D
Review: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2016;221:609-621
Troponin and exercise
Gresslien T; Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2016;2(4):207-208
The application to MEDLINE from European Heart Journal-Cardiovascular Pharmacotherapy has been accepted!
Agewall S
Review: EUROPEAN HEART JOURNAL. 2016;37(27):2129-U130
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski P; Voors AA; Anker SD; Bueno H; Cleland JGF; Coats AJS; Falk V; Ramon Gonzalez-Juanatey J; Harjola V-P; Jankowska EA; Jessup M; Linde C; Nihoyannopoulos P; Parissis JT; Pieske B; Riley JP; Rosano GMC; Ruilope LM; Ruschitzka F; Rutten FH; van der Meer P
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2016;2(3):141
News from EHJCVP
Agewall S
Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2016;75:704
METHOTREXATE AND ANTI-TNF TREATMENT IMPROVE ENDOTHELIAL FUNCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS
Deyab G; Hokstad I; Smastuen MC; Agewall S; Hollan I
Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2016;75:992-993
ANTI-RHEUMATIC TREATMENT IS NOT ASSOCIATED WITH REDUCTION OF PENTRAXIN 3 (PTX3) IN RHEUMATOID ARTHRITIS (RA), PSORIATIC ARTHRITIS (PSA) AND ANKYLOSING SPONDYLITIS (AS)
Deyab G; Hokstad I; Agewall S; Lyberg T; Whist JE; Smastuen MC; Bottazzi BB; Hjeltnes GG; Meroni PL; Hollan I
Review: EUROPEAN HEART JOURNAL. 2016;37(13):1015-1023
Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology
Schmidt M; Lamberts M; Olsen A-MS; Fosboll E; Niessner A; Tamargo J; Rosano G; Agewall S; Kaski JC; Kjeldsen K; Lewis BS; Torp-Pedersen C
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2016;2(2):108-118
Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology
Schmidt M; Lamberts M; Olsen A-MS; Fosboll E; Niessner A; Tamargo J; Rosano G; Agewall S; Kaski JC; Kjeldsen K; Lewis BS; Torp-Pedersen C
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2016;2(2):77-78
Update from EHJ CVP
Agewall S
Editorial comment: EUROPEAN HEART JOURNAL. 2016;37(3):253-255
Morphine in myocardial infarction: balancing on the tight rope
Atar D; Agewall S
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2016;68
Methotrexate and Anti-Tumor Necrosis Treatment Improve Endothelial Function in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Deyab G; Hokstad I; Agewall S; Lyberg T; Whist JE; Smastuen MC; Hjeltnes G; Hollan I
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2016;68
Effect of Anti-Rheumatic Treatment on Selenium Levels in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Deyab G; Hokstad I; Smastuen MC; Agewall S; Whist JE; Hollan I
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2016;18:291
Statins attenuate but not eliminate the reverse epidemiology of total serum cholesterol in patients with non-ischemic chronic heart failure
Froehlich HH; Taeger T; Goode K; Grundtvig M; Hole T; Cleland JFG; Katus HA; Agewall S; Clark AL; Frankenstein L
Review: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2016;202:870-873
Morphine in the treatment of acute pulmonary oedema - Why?
Ellingsrud C; Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2016;2(1):3-4
Annual report of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Lewis BS; Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2016;2(1):1-2
Second year of a journal
Agewall S
Review: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2015;196:133-138
New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint
Rubboli A; Agewall S; Huber K; Lip GYH
Review: AUTOIMMUNITY REVIEWS. 2015;14(10):952-969
Prevention of cardiovascular disease in rheumatoid arthritis
Hollan I; Dessein PH; Ronda N; Wasko MC; Svenungsson E; Agewall S; Cohen-Tervaert JW; Maki-Petaja K; Grundtvig M; Karpouzas GA; Meroni PL
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2015;1(4):213
Starting up a new Journal within the European Heart Journal Family.
Agewall S
Letter: TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING. 2015;135(15):1337
Re: Different guidelines for the treatment of prostate cancer
Agewall S
Review: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2015;192:72-81
Atherosclerosis: Recent trials, new targets and future directions
Ladeiras-Lopes R; Agewall S; Tawakol A; Staels B; Stein E; Mentz RJ; Leite-Moreira A; Zannad F; Koenig W
Review: ANNALS OF INTERNAL MEDICINE. 2015;163(1):40-51
Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia A Systematic Review and Meta-analysis
Navarese EP; Kolodziejczak M; Schulze V; Gurbel PA; Tantry U; Lin Y; Brockmeyer M; Kandzari DE; Kubica JM; D'Agostino RBS; Kubica J; Volpe M; Agewall S; Kereiakes DJ; Kelm M
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2015;1(3):149
Cardiovascular Pharmacotherapy is moving!
Agewall S
Editorial comment: ATHEROSCLEROSIS. 2015;240(2):387-388
How to save six million people per year
Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2015;1(2):73
European Heart Journal - CVP: what is next?
Agewall S
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2015;17:272
Carvedilol compared to metoprolol succinate in the treatment and prognosis of patients with stable chronic heart failure. The Carvedilol or Metoprolol Evaluation Study (COMES)
Froehlich HH; Zhao J; Taeger T; Schellberg D; Katus HA; Grundtvig M; Hole T; Atar D; Agewall S; Frankenstein L
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2015;1(1):46-47
End of story? Studies on prevention of reperfusion injury encounter perpetual defeats
Atar D; Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2015;1(1):1
European Heart Journal - Cardiovascular Pharmacotherapy: a new journal within the European Heart Journal family
Agewall S
Review: TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING. 2014;134(23-24):2272-2275
[Morphine in the treatment of acute pulmonary oedema].
Ellingsrud C; Agewall S
Editorial comment: EUROPEAN HEART JOURNAL. 2014;35(34):2264-2265
What does the future hold for Mayo Clinic?
Nicholls M
Review: EUROPEAN HEART JOURNAL. 2014;35(30):2001-2009
The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials
Anker SD; Agewall S; Borggrefe M; Calvert M; Caro JJ; Cowie MR; Ford I; Paty JA; Riley JP; Swedberg K; Tavazzi L; Wiklund I; Kirchhof P
Letter: LAKARTIDNINGEN. 2014;111(9-10):405
[Final reply: follow the Danish example].
Agewall S
Editorial comment: EUROPEAN HEART JOURNAL. 2014;35(5):266-267
Sick leave and a smoking ban
Agewall S
Letter: LAKARTIDNINGEN. 2014;111(5):129
[Why all these guidelines?].
Agewall S
Letter: HEART. 2014;100(1):81
The association between apnoea-hypopnoea index and flow-mediated dilation of brachial artery.
Kawada T
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2014;66:S170
Anti-Rheumatic Therapy Decreases Syndecan-1 Shedding in Rheumatoid Arthritis (RA)
Hollan I; Hjeltnes G; Lyberg T; Agewall S; Wiik A; Mikkelsen K; Forre OT; Vuong TT; Kolset SO
Conference publication: EUROPEAN HEART JOURNAL. 2014;35:483-484
Cardiac troponin I for prediction of clinical outcomes and cardiac function through three months follow-up after primary percutaneous coronary intervention for ST-elevation myocardial infarction
Hall TS; Hallen J; Krucoff MW; Roe MT; Brennan DM; Agewall S; Atar D; Lincoff AM
Conference publication: EUROPEAN HEART JOURNAL. 2014;35:364
Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: analysis from High Risk Myocardial Infarction Database Initiative
Von Lueder TG; Girerd N; Atar D; Agewall S; Lamiral Z; Dickstein K; Zannad F; Rossignol P
Conference publication: INTERNATIONAL JOURNAL OF STROKE. 2014;9:27
Inflammatory markers and extent and progression of early atherosclerosis: Pooled analysis of individual participant data from 20 prospective studies of the PROG-IMT collaboration
Willeit P; Thompson SG; Agewall S; Bergstrom G; Bickel H; Catapano AL; Chien KL; de Groot E; Empana JP; Etgen T; Franco OH; Iglseder B; Johnsen SH; Kavousi M; Lind L; Liu J; Mathiesen EB; Norata GD; Olsen MH; Papagianni A; Poppert H; Price JF; Sacco RL; Yanez DN; Zhao D; Schminke U; Buelbuel A; Polak JF; Sitzer M; Hofman A; Grigore L; Doerr M; Su TC; Ducimetiere P; Xie W; Ronkainen K; Kiechl S; Rundek T; Robertson C; Fagerberg B; Bokemark L; Steinmetz H; Ikram MA; Voelzke H; Lin HJ; Plichart M; Tuomainen TP; Desvarieux M; McLachlan S; Schmidt C; Kauhanen J; Willeit J; Lorenz MW; Sander D
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2014;16:68-69
Association between spironolactone added to beta blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction: a propensity score-matched cohort study
Froehlich H; Frankenstein L; Katus HA; Grundtvig M; Hole T; De Blois J; Schellberg D; Atar D; Zugck C; Agewall S
Letter: HEART. 2014;100(1):81-82
The association between apnoea-hypopnoea index and flow-mediated dilation of brachial artery REPLY
Namtvedt SK; Hisdal J; Randby A; Agewall S; Rosjo H; Omland T
Editorial comment: INTERNATIONAL ANGIOLOGY. 2013;32(6):608-612
Requirements for Angiology/Vascular Medicine
Catalano M; Poredos P; Brodmann M; Wautrecht JC; Carpentier P; Roztocil K; Nikol S; Diamantopoulos E; Pecsvarady Z; Carlizza A; Sieron A; Stanek A; Olinic D; Stvrtinova V; Kozak M; Agewall S; Gallino A; Jaeger KA; Fitzgerald P; Colgan MP
Review: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2013;167(5):1772-1782
Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges
Zannad F; Stough WG; Regnault V; Gheorghiade M; Deliargyris E; Gibson CM; Agewall S; Berkowitz SD; Burton P; Calvo G; Goldstein S; Verheugt FWA; Koglin J; O'Connor CM
Letter: HEART. 2013;99(13):969
Impaired endothelial function in obstructive sleep apnoea: Allometric scaling can help estimate the true difference in flow-mediated response reply
Hisdal J; Agewall S; Omland T
Letter: ANGIOLOGY. 2013;64(3):245-246
Thyroid Dysfunction in Patients With Myocardial Infarction With Normal Coronary Arteries
Agewall S; Tornvall P
Conference publication: EUROPEAN HEART JOURNAL. 2013;34:997-998
Presence of eNOS TT genotype is associated with a poor prognosis in patients with a previous myocardial infarction
Agewall S; Henareh L; Norman B
Editorial comment: ATHEROSCLEROSIS. 2012;224(2):320-321
Can increased arterial stiffness in women relative to men be explained by their progressive loss of gluteofemoral fat?
Griffin BA; Agewall S
Editorial comment: ATHEROSCLEROSIS. 2012;224(2):324-325
Non-alcoholic fatty liver disease and cardiovascular disease
Santos RD; Agewall S
Review: ATHEROSCLEROSIS. 2012;224(1):12-24
Ultrasound and radiology surrogate endpoints in pharmacological studies
Agewall S; deGroot E; Marcos-Alberca P; Zamorano JL; Barrero AA; Badano LP; Perrone-Filardi P
Letter: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2012;157(1):128-129
Low self-estimated quality of life after myocardial infarction and future cardiovascular risk
Agewall S; Henareh L
Letter: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2012;41(3):240-242
Endothelial function improves within 6 weeks of treatment with methotrexate or methotrexate in combination with a TNF-α inhibitor in rheumatoid arthritis patients
Hjeltnes G; Hollan I; Forre O; Wiik A; Lyberg T; Mikkelsen K; Agewall S
Editorial comment: ATHEROSCLEROSIS. 2012;220(2):319-320
Early arterial abnormalities in young adulthood
Rubba P; Agewall S
Conference publication: EUROPEAN HEART JOURNAL. 2012;33:1057-1058
Low self-estimated quality of life after myocardial infarction and future cardiovascular risk
Agewall S; Henareh L
Conference publication: EUROPEAN HEART JOURNAL. 2012;33:184-185
Myocardial infarction with normal coronary arteries is common and associated with normal findings on CMR - results from the Stockholm Myocardial Infarction with Normal Coronaries (SMINC) Study
Collste O; Sorensson P; Frick M; Agewall S; Daniel M; Jernberg T; Hofman-Bang C; Malmqvist K; Arheden H; Tornvall P
Review: REVISTA ESPANOLA DE CARDIOLOGIA. 2011;64(12):1168.e1-1168.e60
[ESC/EAS Guidelines for the management of dyslipidaemias].
Reiner Ž; Catapano AL; De Backer G; Graham I; Taskinen M-R; Wiklund O; Agewall S; Alegría E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs RH; Kjekshus JK; Perrone Filardi P; Riccardi G; Storey RF; David W; Clinical Practice Guidelines Committee of the Span
Review: ATHEROSCLEROSIS. 2011;219(1):10-14
Myocardial infarction with angiographically normal coronary arteries
Agewall S; Eurenius L; Hofman-Bang C; Malmqvist K; Frick M; Jernberg T; Tornvall P
Review: FUNDAMENTAL & CLINICAL PHARMACOLOGY. 2011;25(5):564-571
Oral antiplatelet agents in ACS: from pharmacology to clinical differences
Agewall S; Badimon L; Drouet L; Eschenhagen T; Husted S; Simon T; Steg G
Letter: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2011;151(3):375-376
Troponin rise in healthy subjects during exercise test
Tjora S; Gjestland H; Mordal S; Agewall S
Review: ATHEROSCLEROSIS. 2011;217(1):3-46
ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
Catapano AL; Reiner Z; De Backer G; Graham I; Taskinen M-R; Wiklund O; Agewall S; Alegria E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Filardi PP; Riccardi G; Storey RF; Wood D
Corrigendum: ATHEROSCLEROSIS. 2011;217(1):S1-44
ESC/EAS Guidelines for the management of dyslipidaemias (vol 32, pg 1769, 2011)
Catapano AL; Reiner Z; De Backer G; Graham I; Taskinen M-R; Wiklund O; Agewall S; Alegria E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Filardi PP; Riccardi G; Storey RF; Wood D
Letter: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2011;150(1):108-111
The large clinical statin trials
Agewall S
Meeting abstract: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2011;57(14):E1080
EXCELLENT EARLY RISK STRATIFICATION USING TROPONINS AND N-TERMNIAL PRO-BRAIN NATRIURETIC PEPTIDES IN CHEST PAIN PATIENTS BUT NO ADDITIONAL VALUE OF HIGH-SENSITIVE TROPONIN T
Melki D; Lind S; Agewall S; Jernberg T
Editorial comment: ATHEROSCLEROSIS. 2011;215(1):32-33
Ivabradine: An hypothesis generating study - An important link between bench and bedside
Wellnhofer E; Agewall S
Letter: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2011;147(1):139-140
Sweet dreams might be bad
Agewall S; Nesvold A
Review: EUROPEAN HEART JOURNAL. 2011;32(4):404-411
Troponin elevation in coronary vs. non-coronary disease
Agewall S; Giannitsis E; Jernberg T; Katus H
Conference publication: EUROPEAN HEART JOURNAL. 2011;32:323
Prevention of peptic ulcers with once-daily esomeprazole 20 mg and 40 mg in low-dose acetylsalicylic acid users at gastrointestinal risk: outcome analysis by cardiovascular risk (OBERON)
Scheiman J; Agewall S; Svedberg L-E; Naucler E; Nagy P
Editorial comment: ATHEROSCLEROSIS. 2010;210(2):366
Never too late: A commentary on "Impact of age, sex and exercise on brachial and popliteal artery remodelling in humans"
Barth J; Agewall S
Meeting abstract: JOURNAL OF HYPERTENSION. 2010;28:e165
EARLY PREDICTORS OF CARDIOVASCULAR DISEASE (CVD) RISK: A 15-YEAR FOLLOW-UP STUDY OF 108 PATIENTS WITH RHEUMATOID ARTHRITIS (RA)
Provan S; Angel K; Semb AG; Agewall S; Atar D; Kvien TK
Review: PROGRESS IN CARDIOVASCULAR DISEASES. 2010;52(5):410-428
Matrix Metalloproteinases in Atherothrombosis
Back M; Ketelhuth DFJ; Agewall S
Review: EUROPEAN JOURNAL OF ANAESTHESIOLOGY. 2010;27(2):92-137
Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA).
Poldermans D; Bax JJ; Boersma E; De Hert S; Eeckhout E; Fowkes G; Gorenek B; Hennerici MG; Iung B; Kelm M; Kjeldsen KP; Kristensen SD; Lopez-Sendon J; Pelosi P; Philippe F; Pierard L; Ponikowski P; Schmid J-P; Sellevold OF; Sicari R; Van den Berghe G; Vermassen F; Hoeks SE; Vanhorebeek I; Vahanian A; Auricchio A; Bax JJ; Ceconi C; Dean V; Filippatos G; Funck-Brentano C; Hobbs R; Kearn P; McDonag T; McGregor K; Popescu BA; Reiner Z; Sechtem U; Sirnes PA; Tendera M; Vardas P; Widimsky P; De Caterina R; Agewall S; Al Attar N; Andreotti F; Anker SD; Baron-Esquivias G; Berkenboom G; Chapoutot L; Cifkova R; Faggiano P; Gibbs S; Hansen HS; Iserin L; Israel CW; Kornowski R; Eizagaechevarria NM; Pepi M; Piepoli M; Priebe HJ; Scherer M; Stepinska J; Taggart D; Tubaro M; Task Force for Preoperative Cardiac Risk Assessmen; European Society of Anaesthesiology (ESA)
Conference publication: EUROPEAN HEART JOURNAL. 2010;31:847
Beta blockers, statins and recommended doses of ACE-I improve survival in non-randomized patients with heart failure. A propensity score analysis of the Norwegian Heart Failure Registry
De Blois J; Fagerland MW; Grundtvig M; Gullestad L; Westheim A; Hole T; Atar D; Agewall S
Conference publication: EUROPEAN HEART JOURNAL. 2010;31:674
Esomeprazole 20 mg and 40 mg for 26 weeks reduces the frequency of upper GI symptoms in patients taking low-dose acetylsalicylic acid (ASA) for cardiovascular prevention: the OBERON trial
Scheiman J; Herlitz J; Agewall S; Lanas A; Van Zanten SV; Naucler E; Svedberg L-E
Conference publication: EUROPEAN HEART JOURNAL. 2010;31:375
Peptic ulcer prevention by esomeprazole 20 mg and 40 mg once daily in patients taking low-dose acetylsalicylic acid for secondary cardiovascular prevention
Scheiman J; Herlitz J; Agewall S; Lanas A; Van Zanten SV; Naucler E; Svedberg L-E
Editorial comment: REVISTA PORTUGUESA DE CARDIOLOGIA. 2010;29(7-8):1273
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Swedberg K; Komajda M; Boehm M; Borer JS; Ford I; Dubost-Brama A; Lerebours G; Tavazzi L
Review: EUROPEAN HEART JOURNAL. 2009;37(22):2769-2812
Pre-operative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-Cardiac Surgery
Baskan DP; Bax JJ; Boersma E; De Hert S; Eeckhout E; Fowkes G; Gorenek B; Hennerci MG; Lung B; Kelm M; Kjeldsen KP; Kristensen SD; Lopez-Sendon J; Pelosi P; Philippe F; Pierard L; Ponikowski P; Schmid J-P; Sellevold OFM; Sicari R; Van den Berghe G; Vermassen F; Hoeks SE; Vanhorebeek I; Kurulu UK; Vahanian A; Auricchio A; Bax JJ; Ceconi C; Dean V; Filippatos G; Funck-Brentano C; Hobbs R; Kearney P; McDonagh T; McGregor K; Popescu BA; Reiner Z; Sechtem U; Sirnes PA; Tendera M; Vardas P; Widimsky P; De Caterina R; Agewall S; Al Attar N; Andreotti F; Anker SD; Baron-Esquivias G; Berkenboom G; Chapoutot L; Cifkova R; Faggiano P; Gibbs S; Hansen HS; Iserin L; Israel CW; Kornowski R; Eizagaechevarria NM; Pepi M; Piepoli M; Priebe HJ; Scherer M; Stepinska J; Taggart D; Tubaro M
Letter: FUNDAMENTAL & CLINICAL PHARMACOLOGY. 2009;23(2):261-262
Interpreting clinical trials: the 'Beautiful' case
Agewall S; Atar D
Review: ATHEROSCLEROSIS. 2009;202(2):330-344
Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease
Luksha L; Agewall S; Kublickiene K
Conference publication: EUROPEAN HEART JOURNAL. 2009;30:876
COPD predicts mortality in CHF: the Norwegian Heart Failure Registry
De Blois J; Simard S; Atar D; Agewall S
Conference publication: EUROPEAN HEART JOURNAL. 2009;30:762
Increased CRP early in the RA disease course predicts cardiovascular disease and arterial stiffness. 15-year follow-up of the EURIDISS cohort
Provan S; Angel K; Semb AG; Mowinckel P; Agewall S; Atar D; Kvien TK
Editorial comment: EUROPEAN HEART JOURNAL. 2008;29(16):1927-1929
Acute and stable coronary heart disease: different risk factors
Agewall S
Letter: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2008;123(2):195-196
Clopidogrel inhibits platelet aggregation in patients on aspirin with stable chronic angina pectoris
Saha S; Berglund M; Sylven C; Gordon A; Agewall S
Conference publication: EUROPEAN HEART JOURNAL. 2008;29:183
Gender differences in Norwegian patients with heart failure
Agewall S; Brandsaeter B; Atar D
Review: LAKARTIDNINGEN. 2007;104(37):2586-2588
[Myocardial infarction with normal coronary arteries in women. MINCA--a specific type of myocardial infarction].
Skeppholm M; Agewall S; Ljungman P; Daniel M; Eriksson M; Hofman-Bang C; Malmqvist K; Reistam U; Svane B; Tornvall P
Editorial comment: GYNECOLOGICAL ENDOCRINOLOGY. 2007;23(7):363-365
Gender issues in cardiovascular medicine
KubliKiene K; Agewall S
Letter: EUROPEAN HEART JOURNAL. 2007;28(4):515
Levosimendan: Perpetuum mobile?
Agewall S; Atar D
Conference publication: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2007;49(9):248A
High-risk patients benefit most from angiotensin-converting enzyme inhibition after an acute myocardial infarction
Milonas C; Jernberg T; Lindback J; Agewall S; Wallentin L; Stenestrand U
Corrigendum: HAEMOSTASIS. 2007;36(2):108
Association between AMPD1 Gene Polymorphism and Coagulation Factors in Patients with Coronary Heart Disease (vol 35, pg 440, 2006)
Agewall S; Henareh L; Jogestrand T; Norman B
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2006;7(3):264
Atorvastatin normalizes endothelial function in healthy smokers
Agewall S; Hernberg A
Conference publication: CIRCULATION. 2006;114(18):700
The impact of renal dysfunction on bleeding and outcome in ST-Elevation MI: Results of the ExTRACT-TIMI25 study
Fox KA; Antman E; Montalescot G; Agewall S; McCabe C; Mohanavelu S; Morrow D; Braunwald E
Conference publication: EUROPEAN HEART JOURNAL. 2006;27:665
Atorvastatin normalizes endothelial function in healthy smokers
Agewall S; Hernberg A
Editorial comment: EUROPEAN HEART JOURNAL. 2006;27(2):121-122
Matrix metalloproteinases and cardiovascular disease
Agewall S
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2006;7(3):397
Influence of AMPD1 gene polymorphism on coagulation factors in patients with coronary heart disease
Agewall S; Norman B
Editorial comment: EUROPEAN HEART JOURNAL. 2005;26(7):634-636
How should we evaluate an open artery in STEMI patients?
Agewall S
Letter: LAKARTIDNINGEN. 2004;101(39):3018
[Bad taste in the mouth because of the article on snuff use].
Agewall S
Letter: EUROPEAN JOURNAL OF EPIDEMIOLOGY. 2004;19(8):819
Snus is not harmless!
Agewall S
Review: CURRENT VASCULAR PHARMACOLOGY. 2003;1(2):107-109
Is impaired flow-mediated dilatation of the brachial artery a cardiovascular risk factor?
Agewall S
Letter: LANCET. 2003;361(9369):1659
Clever idiot?
Agewall S
Letter: LAKARTIDNINGEN. 2003;100(4):250
[A clever idiot?].
Agewall S
Conference publication: CIRCULATION. 2001;104(17):476
The increased vasodilatation of the brachial artery after ischaemic handgrip exercise during forearm occlusion is nitric oxide mediated.
Agewall S; Fagerberg B; Hulthe J; Gottfridsson B; Wikstrand J
Letter: CLINICAL CHEMISTRY. 2000;46(12):2016-2017
Increases of creatine kinase MB and cardiac troponin T in serum of a patient with uterine leiomyosarcoma
Agewall S
Letter: EUROPEAN HEART JOURNAL. 2000;21(17):1482-1483
Impact of red wine on antioxidant status in vivo -: A reply
Agewall S; Doughty RN
Conference publication: EUROPEAN HEART JOURNAL. 2000;21:489
Multiple risk intervention trial in high risk hypertensive men
Agewall S; Fagerberg B; Berglund G; Schmidt C; Wendelhag I; Wikstrand J
Conference publication: CIRCULATION. 2000;102(18):519
Multiple risk intervention trial in high-risk hypertensive men: Comparison of ultrasound intima-media thickness and clinical outcome during six years of follow-up
Agewall S; Schmidt C; Fagerberg B; John W; Berglund G; Wendelhag I
Conference publication: CIRCULATION. 1998;98(17):502
Under-estimation of LV end-systolic volume & over-estimation of LV ejection fraction with Levovist is avoided by EGG triggered Power Motion Imaging.
Doughty RN; Whalley GA; Wright S; Agewall S; Walsh HJ
Letter: JOURNAL OF HYPERTENSION. 1998;16(10):1555
Prothrombin fragment 1+2 is a risk factor for myocardial infarction in treated hypertensive men - Reply
Agewall S; Wikstrand J; Fagerberg B
Letter: JOURNAL OF HYPERTENSION. 1998;16(10):1558-1559
Prothrombin fragment 1+2 is a risk factor for myocardial infarction in treated hypertensive men - Reply
Agewall S; Wikstrand J; Fagerberg B
Review: JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. 1997;22(3):171-179
Treatment with β-blockers -: the value of an even plasma concentration over 24 h
Agewall S; Kendall M
Conference publication: CIRCULATION. 1997;96(8):2265
Ultrasound measurements of the carotid and femoral arteries in a randomized multiple risk factor intervention trial in treated hypertensive men at high cardiovascular risk
Agewall S; Wikstrand J; Fagerberg B
Corrigendum: JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. 1997;22(4):303
Treatment with β-blockers -: the value of an even plasma concentration over 24 h (vol 22, pg 171, 1997)
Agewall S; Kendall M
Conference publication: CIRCULATION. 1996;94(8):2669
Prothrombin fragment 1+2 is a risk factor for myocardial infarction and mortality in treated hypertensive men
Agewall S; Fagerberg B; Wikstrand J
Visa fler

Forskningsbidrag

Randomized Evaluation of Beta-blocker and ACEI/ARB Treatment in MINOCA patients (MINOCA-BAT).
Swedish Research Council
1 December 2017 - 31 December 2018
Regional network for Heart Failure Research
Southern and Eastern Norway Regional Health Authority
1 January 2016 - 31 December 2019
Cardiac magnetic resonance imaging in myocardial infarction with normal coronary arteries
Swedish Research Council
1 January 2014 - 31 December 2016
Center for Heart Failure Research; a regional research network
Southern and Eastern Norway Regional Health Authority
1 January 2013 - 31 December 2015
Novel biomarkers for improvement of diagnostic and prognostic evaluation in patients at risk for myocardial cell injury.
Southern and Eastern Norway Regional Health Authority
1 January 2013 - 31 December 2016
A structuralised sick-leave program compared to usual care sick leave management in patients after an acute myocardial infarction
Southern and Eastern Norway Regional Health Authority
1 January 2009 - 31 December 2015

Anställningar

Anknuten till Forskning, Kliniska vetenskaper, Danderyds sjukhus, Karolinska Institutet, 2024-2026
Gästprofessor, Kliniska vetenskaper, Danderyds sjukhus, Karolinska Institutet, 2023-2024

Examina och utbildning

Docent

Om mig

Forskningsbeskrivning

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI